CHEBI ONTOLOGY - ANNOTATIONS |
|
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
|
|
G |
Abcb1b |
ATP-binding cassette, sub-family B member 1B |
increases expression |
EXP |
echimidine results in increased expression of ABCB1B mRNA |
CTD |
PMID:32419051 |
|
NCBI chr 4:25,242,761...25,325,194
Ensembl chr 4:25,242,798...25,325,199
|
|
G |
Actn2 |
actinin alpha 2 |
decreases expression |
EXP |
echimidine results in decreased expression of ACTN2 mRNA |
CTD |
PMID:34185104 |
|
NCBI chr17:58,143,334...58,210,622
Ensembl chr17:58,142,625...58,210,622
|
|
G |
Adam8 |
ADAM metallopeptidase domain 8 |
increases expression |
EXP |
echimidine results in increased expression of ADAM8 mRNA |
CTD |
PMID:32419051 |
|
NCBI chr 1:194,776,559...194,789,330
Ensembl chr 1:194,770,060...194,788,801
|
|
G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
increases expression |
EXP |
echimidine results in increased expression of ALDH1A1 mRNA |
CTD |
PMID:32419051 |
|
NCBI chr 1:218,000,470...218,152,962
Ensembl chr 1:218,042,127...218,152,961
|
|
G |
Anapc2 |
anaphase promoting complex subunit 2 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of echimidine] which results in decreased expression of ANAPC2 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 3:8,086,434...8,098,182
Ensembl chr 3:8,086,462...8,098,178
|
|
G |
Ankrd1 |
ankyrin repeat domain 1 |
decreases expression |
EXP |
echimidine results in decreased expression of ANKRD1 mRNA |
CTD |
PMID:34185104 |
|
NCBI chr 1:233,815,851...233,834,891
Ensembl chr 1:233,815,851...233,834,919
|
|
G |
Aurka |
aurora kinase A |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of echimidine] which results in decreased expression of AURKA mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 3:161,128,309...161,144,524
Ensembl chr 3:161,128,313...161,144,390
|
|
G |
C3ar1 |
complement C3a receptor 1 |
increases expression |
EXP |
echimidine results in increased expression of C3AR1 mRNA |
CTD |
PMID:34185104 |
|
NCBI chr 4:156,074,747...156,084,680
Ensembl chr 4:156,075,389...156,084,701
|
|
G |
Casp3 |
caspase 3 |
multiple interactions |
ISO |
echimidine results in increased activity of and results in increased cleavage of CASP3 protein |
CTD |
PMID:29458164 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp8 |
caspase 8 |
multiple interactions |
ISO |
echimidine results in increased activity of and results in increased cleavage of CASP8 protein |
CTD |
PMID:29458164 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
increases activity |
ISO |
echimidine results in increased activity of CASP9 protein |
CTD |
PMID:29458164 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Ccnb1 |
cyclin B1 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of echimidine] which results in decreased expression of CCNB1 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Ccnb2 |
cyclin B2 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of echimidine] which results in decreased expression of CCNB2 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 8:71,087,594...71,100,794
Ensembl chr 8:71,087,595...71,100,874
|
|
G |
Cdc16 |
cell division cycle 16 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of echimidine] which results in increased expression of CDC16 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr16:75,773,026...75,796,586
Ensembl chr16:75,773,028...75,796,550
|
|
G |
Cdc20 |
cell division cycle 20 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of echimidine] which affects the expression of CDC20 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 5:131,966,203...131,970,406
Ensembl chr 5:131,966,215...131,970,512
|
|
G |
Cdc25b |
cell division cycle 25B |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of echimidine] which results in decreased expression of CDC25B mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 3:118,407,127...118,417,272
Ensembl chr 3:118,407,128...118,417,272
|
|
G |
Cdc25c |
cell division cycle 25C |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of echimidine] which results in decreased expression of CDC25C mRNA |
CTD |
PMID:33884520 |
|
NCBI chr18:26,335,156...26,356,199
Ensembl chr18:26,335,834...26,356,185
|
|
G |
Cdk1 |
cyclin-dependent kinase 1 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of echimidine] which results in decreased expression of CDK1 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
|
|
G |
Cdk2 |
cyclin dependent kinase 2 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of echimidine] which results in decreased expression of CDK2 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
increases expression multiple interactions |
EXP ISO |
echimidine results in increased expression of CDKN1A mRNA [CYP3A4 protein results in increased metabolism of echimidine] which results in increased expression of CDKN1A mRNA |
CTD |
PMID:32419051 PMID:33884520 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Chek1 |
checkpoint kinase 1 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of echimidine] which results in decreased expression of CHEK1 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 8:36,420,565...36,443,477
Ensembl chr 8:36,420,569...36,441,009
|
|
G |
Ckap2 |
cytoskeleton associated protein 2 |
increases expression |
EXP |
echimidine results in increased expression of CKAP2 mRNA |
CTD |
PMID:32419051 |
|
NCBI chr16:69,839,668...69,864,852
Ensembl chr16:69,839,630...69,864,913
|
|
G |
Ckm |
creatine kinase, M-type |
decreases expression |
EXP |
echimidine results in decreased expression of CKM mRNA |
CTD |
PMID:34185104 |
|
NCBI chr 1:79,061,390...79,071,721
Ensembl chr 1:79,061,456...79,071,720
|
|
G |
Ckmt2 |
creatine kinase, mitochondrial 2 |
decreases expression |
EXP |
echimidine results in decreased expression of CKMT2 mRNA |
CTD |
PMID:34185104 |
|
NCBI chr 2:23,079,918...23,110,518
Ensembl chr 2:23,079,918...23,110,430
|
|
G |
Clec4f |
C-type lectin domain family 4, member F |
decreases expression |
EXP |
echimidine results in decreased expression of CLEC4F mRNA |
CTD |
PMID:32419051 |
|
NCBI chr 4:116,129,023...116,138,744
Ensembl chr 4:116,129,023...116,138,775
|
|
G |
Cox6a2 |
cytochrome c oxidase subunit 6A2 |
decreases expression |
EXP |
echimidine results in decreased expression of COX6A2 mRNA |
CTD |
PMID:34185104 |
|
NCBI chr 1:182,788,528...182,790,746
Ensembl chr 1:182,788,528...182,789,274
|
|
G |
Csf1r |
colony stimulating factor 1 receptor |
decreases expression |
EXP |
echimidine results in decreased expression of CSF1R mRNA |
CTD |
PMID:32419051 |
|
NCBI chr18:54,546,673...54,590,418
Ensembl chr18:54,546,659...54,590,415
|
|
G |
Csrp3 |
cysteine and glycine rich protein 3 |
decreases expression |
EXP |
echimidine results in decreased expression of CSRP3 mRNA |
CTD |
PMID:34185104 |
|
NCBI chr 1:98,528,067...98,546,647
Ensembl chr 1:98,528,068...98,546,653
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
increases metabolic processing increases response to substance multiple interactions |
ISO |
CYP3A4 protein results in increased metabolism of echimidine CYP3A4 protein results in increased susceptibility to echimidine [CYP3A4 protein results in increased metabolism of echimidine] which affects the expression of CDC20 mRNA; [CYP3A4 protein results in increased metabolism of echimidine] which affects the expression of PKMYT1 mRNA; [CYP3A4 protein results in increased metabolism of echimidine] which affects the expression of PLK2 mRNA; [CYP3A4 protein results in increased metabolism of echimidine] which results in decreased expression of ANAPC2 mRNA; [CYP3A4 protein results in increased metabolism of echimidine] which results in decreased expression of AURKA mRNA; [CYP3A4 protein results in increased metabolism of echimidine] which results in decreased expression of CCNB1 mRNA; [CYP3A4 protein results in increased metabolism of echimidine] which results in decreased expression of CCNB2 mRNA; [CYP3A4 protein results in increased metabolism of echimidine] which results in decreased expression of CDC25B mRNA; [CYP3A4 protein results in increased metabolism of echimidine] which results in decreased expression of CDC25C mRNA; [CYP3A4 protein results in increased metabolism of echimidine] which results in decreased expression of CDK1 mRNA; [CYP3A4 protein results in increased metabolism of echimidine] which results in decreased expression of CDK2 mRNA; [CYP3A4 protein results in increased metabolism of echimidine] which results in decreased expression of CHEK1 mRNA; [CYP3A4 protein results in increased metabolism of echimidine] which results in decreased expression of ESPL1 mRNA; [CYP3A4 protein results in increased metabolism of echimidine] which results in decreased expression of FBXO5 mRNA; [CYP3A4 protein results in increased metabolism of echimidine] which results in decreased expression of KIF11 mRNA; [CYP3A4 protein results in increased metabolism of echimidine] which results in decreased expression of PLK1 mRNA; [CYP3A4 protein results in increased metabolism of echimidine] which results in decreased expression of PLK4 mRNA; [CYP3A4 protein results in increased metabolism of echimidine] which results in decreased expression of PPM1L mRNA; [CYP3A4 protein results in increased metabolism of echimidine] which results in decreased expression of PPP2R5D mRNA; [CYP3A4 protein results in increased metabolism of echimidine] which results in decreased expression of PRC1 mRNA; [CYP3A4 protein results in increased metabolism of echimidine] which results in decreased expression of PTTG1 mRNA; [CYP3A4 protein results in increased metabolism of echimidine] which results in decreased expression of RAD21 mRNA; [CYP3A4 protein results in increased metabolism of echimidine] which results in decreased expression of STAG2 mRNA; [CYP3A4 protein results in increased metabolism of echimidine] which results in increased expression of CDC16 mRNA; [CYP3A4 protein results in increased metabolism of echimidine] which results in increased expression of CDKN1A mRNA; [CYP3A4 protein results in increased metabolism of echimidine] which results in increased expression of KIF23 mRNA; [CYP3A4 protein results in increased metabolism of echimidine] which results in increased expression of PLK3 mRNA; [CYP3A4 protein results in increased metabolism of echimidine] which results in increased expression of PPP2CB mRNA; [CYP3A4 protein results in increased metabolism of echimidine] which results in increased expression of PPP2R5E mRNA |
CTD |
PMID:32910235 PMID:33884520 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Dnase1l3 |
deoxyribonuclease 1L3 |
decreases expression |
EXP |
echimidine results in decreased expression of DNASE1L3 mRNA |
CTD |
PMID:34185104 |
|
NCBI chr15:16,922,335...16,948,322
Ensembl chr15:16,922,335...16,948,317
|
|
G |
Eda2r |
ectodysplasin A2 receptor |
increases expression |
EXP |
echimidine results in increased expression of EDA2R mRNA |
CTD |
PMID:32419051 |
|
NCBI chr X:62,224,763...62,269,333
Ensembl chr X:62,228,229...62,269,268
|
|
G |
Eef1a2 |
eukaryotic translation elongation factor 1 alpha 2 |
decreases expression |
EXP |
echimidine results in decreased expression of EEF1A2 mRNA |
CTD |
PMID:34185104 |
|
NCBI chr 3:168,265,893...168,275,071
Ensembl chr 3:168,195,357...168,275,071
|
|
G |
Espl1 |
extra spindle pole bodies like 1, separase |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of echimidine] which results in decreased expression of ESPL1 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 7:133,424,027...133,450,984
Ensembl chr 7:133,424,130...133,450,984
|
|
G |
Fas |
Fas cell surface death receptor |
increases expression |
ISO |
echimidine metabolite results in increased expression of FAS mRNA |
CTD |
PMID:30465738 |
|
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Fbxo5 |
F-box protein 5 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of echimidine] which results in decreased expression of FBXO5 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 1:42,196,068...42,202,437
Ensembl chr 1:42,196,068...42,202,437
|
|
G |
Fcgr3a |
Fc gamma receptor 3A |
increases expression |
EXP |
echimidine results in increased expression of FCGR3A mRNA |
CTD |
PMID:34185104 |
|
NCBI chr13:83,249,905...83,259,921
Ensembl chr13:83,249,872...83,259,921
|
|
G |
Gpc1 |
glypican 1 |
decreases expression |
EXP |
echimidine results in decreased expression of GPC1 mRNA |
CTD |
PMID:34185104 |
|
NCBI chr 9:93,396,234...93,424,047
Ensembl chr 9:93,396,234...93,424,047
|
|
G |
H2ax |
H2A.X variant histone |
increases expression |
ISO |
echimidine results in increased expression of H2AX protein |
CTD |
PMID:31154085 |
|
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239 Ensembl chr 4:44,671,786...44,673,239
|
|
G |
Hjv |
hemojuvelin BMP co-receptor |
decreases expression |
EXP |
echimidine results in decreased expression of HJV mRNA |
CTD |
PMID:34185104 |
|
NCBI chr 2:184,065,944...184,069,851
Ensembl chr 2:184,065,970...184,069,850
|
|
G |
Hpgd |
15-hydroxyprostaglandin dehydrogenase |
decreases expression |
EXP |
echimidine results in decreased expression of HPGD mRNA |
CTD |
PMID:32419051 |
|
NCBI chr16:33,986,265...34,024,228
Ensembl chr16:33,986,266...34,024,228
|
|
G |
Hrc |
histidine rich calcium binding protein |
decreases expression |
EXP |
echimidine results in decreased expression of HRC mRNA |
CTD |
PMID:34185104 |
|
NCBI chr 1:95,813,262...95,816,987
Ensembl chr 1:95,813,253...95,816,984
|
|
G |
Ifit2 |
interferon-induced protein with tetratricopeptide repeats 2 |
increases expression |
EXP |
echimidine results in increased expression of IFIT2 mRNA |
CTD |
PMID:32419051 |
|
NCBI chr 1:232,102,570...232,108,638
Ensembl chr 1:232,102,570...232,108,635
|
|
G |
Inmt |
indolethylamine N-methyltransferase |
decreases expression |
EXP |
echimidine results in decreased expression of INMT mRNA |
CTD |
PMID:32419051 |
|
NCBI chr 4:84,318,197...84,322,493
Ensembl chr 4:84,318,197...84,322,493
|
|
G |
Kif11 |
kinesin family member 11 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of echimidine] which results in decreased expression of KIF11 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 1:235,124,371...235,176,760
Ensembl chr 1:235,124,316...235,176,766
|
|
G |
Kif23 |
kinesin family member 23 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of echimidine] which results in increased expression of KIF23 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 8:62,397,908...62,425,162
Ensembl chr 8:62,397,948...62,425,072
|
|
G |
Mal |
mal, T-cell differentiation protein |
increases expression |
EXP |
echimidine results in increased expression of MAL mRNA |
CTD |
PMID:34185104 |
|
NCBI chr 3:114,864,378...114,888,136
Ensembl chr 3:114,864,378...114,888,136
|
|
G |
Mb |
myoglobin |
decreases expression |
EXP |
echimidine results in decreased expression of MB mRNA |
CTD |
PMID:34185104 |
|
NCBI chr 7:108,759,903...108,767,134
Ensembl chr 7:108,759,904...108,767,383
|
|
G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
increases expression |
EXP |
echimidine results in increased expression of MGMT mRNA |
CTD |
PMID:32419051 |
|
NCBI chr 1:191,710,980...191,937,760
Ensembl chr 1:191,710,930...191,937,756
|
|
G |
Mki67 |
marker of proliferation Ki-67 |
increases expression |
EXP |
echimidine results in increased expression of MKI67 mRNA |
CTD |
PMID:32419051 |
|
NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762
|
|
G |
Mybl1 |
MYB proto-oncogene like 1 |
increases expression |
EXP |
echimidine results in increased expression of MYBL1 mRNA |
CTD |
PMID:32419051 |
|
NCBI chr 5:9,582,905...9,618,179
Ensembl chr 5:9,582,934...9,618,183
|
|
G |
Mybpc3 |
myosin binding protein C3 |
decreases expression |
EXP |
echimidine results in decreased expression of MYBPC3 mRNA |
CTD |
PMID:34185104 |
|
NCBI chr 3:77,095,165...77,113,406
Ensembl chr 3:77,095,252...77,113,405
|
|
G |
Myh6 |
myosin heavy chain 6 |
decreases expression |
EXP |
echimidine results in decreased expression of MYH6 mRNA |
CTD |
PMID:34185104 |
|
NCBI chr15:28,418,120...28,442,316
Ensembl chr15:28,417,616...28,441,720
|
|
G |
Myl4 |
myosin, light chain 4 |
decreases expression |
EXP |
echimidine results in decreased expression of MYL4 mRNA |
CTD |
PMID:34185104 |
|
NCBI chr10:89,449,456...89,485,365
Ensembl chr10:89,449,443...89,485,363
|
|
G |
Myoz2 |
myozenin 2 |
decreases expression |
EXP |
echimidine results in decreased expression of MYOZ2 mRNA |
CTD |
PMID:34185104 |
|
NCBI chr 2:211,141,463...211,168,187
Ensembl chr 2:211,141,463...211,168,221
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
multiple interactions |
ISO |
echimidine results in decreased expression of and results in increased cleavage of PARP1 protein |
CTD |
PMID:29458164 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Pkmyt1 |
protein kinase, membrane associated tyrosine/threonine 1 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of echimidine] which affects the expression of PKMYT1 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr10:12,748,221...12,758,995
Ensembl chr10:12,748,237...12,758,995
|
|
G |
Plk1 |
polo-like kinase 1 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of echimidine] which results in decreased expression of PLK1 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 1:176,716,420...176,726,400
Ensembl chr 1:176,716,420...176,726,400
|
|
G |
Plk2 |
polo-like kinase 2 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of echimidine] which affects the expression of PLK2 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 2:41,969,176...41,974,945
Ensembl chr 2:41,969,176...41,974,947
|
|
G |
Plk3 |
polo-like kinase 3 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of echimidine] which results in increased expression of PLK3 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 5:130,607,142...130,612,317
Ensembl chr 5:130,607,142...130,612,317
|
|
G |
Plk4 |
polo-like kinase 4 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of echimidine] which results in decreased expression of PLK4 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 2:123,802,527...123,820,942
Ensembl chr 2:123,802,512...123,820,942
|
|
G |
Pln |
phospholamban |
decreases expression |
EXP |
echimidine results in decreased expression of PLN mRNA |
CTD |
PMID:34185104 |
|
NCBI chr20:32,629,537...32,639,559
|
|
G |
Ppm1l |
protein phosphatase, Mg2+/Mn2+ dependent, 1L |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of echimidine] which results in decreased expression of PPM1L mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 2:153,566,653...153,839,434
Ensembl chr 2:153,566,653...153,839,434
|
|
G |
Ppp2cb |
protein phosphatase 2 catalytic subunit beta |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of echimidine] which results in increased expression of PPP2CB mRNA |
CTD |
PMID:33884520 |
|
NCBI chr16:58,558,119...58,579,325
Ensembl chr16:58,558,122...58,579,576
|
|
G |
Ppp2r5d |
protein phosphatase 2, regulatory subunit B', delta |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of echimidine] which results in decreased expression of PPP2R5D mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 9:14,270,364...14,300,396
Ensembl chr 9:14,268,745...14,300,400
|
|
G |
Ppp2r5e |
protein phosphatase 2 regulatory subunit B', epsilon |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of echimidine] which results in increased expression of PPP2R5E mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 6:94,168,846...94,317,872
Ensembl chr 6:94,168,846...94,317,872
|
|
G |
Prc1 |
protein regulator of cytokinesis 1 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of echimidine] which results in decreased expression of PRC1 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 1:134,250,086...134,271,765
Ensembl chr 1:134,250,081...134,271,765
|
|
G |
Pttg1 |
PTTG1 regulator of sister chromatid separation, securin |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of echimidine] which results in decreased expression of PTTG1 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr10:27,893,466...27,904,965
Ensembl chr10:27,893,689...27,904,837
|
|
G |
Rad21 |
RAD21 cohesin complex component |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of echimidine] which results in decreased expression of RAD21 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 7:83,287,867...83,314,810
Ensembl chr 7:83,287,870...83,314,817
|
|
G |
Slc13a4 |
solute carrier family 13 member 4 |
increases expression |
EXP |
echimidine results in increased expression of SLC13A4 mRNA |
CTD |
PMID:34185104 |
|
NCBI chr 4:63,943,369...63,988,852
Ensembl chr 4:63,943,395...63,988,857
|
|
G |
Sln |
sarcolipin |
decreases expression |
EXP |
echimidine results in decreased expression of SLN mRNA |
CTD |
PMID:34185104 |
|
NCBI chr 8:54,221,389...54,248,110
Ensembl chr 8:54,243,542...54,247,791
|
|
G |
Stac3 |
SH3 and cysteine rich domain 3 |
decreases expression |
EXP |
echimidine results in decreased expression of STAC3 mRNA |
CTD |
PMID:32419051 |
|
NCBI chr 7:63,343,078...63,350,590
Ensembl chr 7:63,343,186...63,350,589
|
|
G |
Stag2 |
STAG2 cohesin complex component |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of echimidine] which results in decreased expression of STAG2 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr X:120,974,687...121,105,677
Ensembl chr X:120,974,857...121,105,677
|
|
G |
Stc1 |
stanniocalcin 1 |
increases expression |
EXP |
echimidine results in increased expression of STC1 mRNA |
CTD |
PMID:34185104 |
|
NCBI chr15:44,299,591...44,311,695
Ensembl chr15:44,299,621...44,310,264
|
|
G |
Tlr8 |
toll-like receptor 8 |
increases expression |
EXP |
echimidine results in increased expression of TLR8 mRNA |
CTD |
PMID:34185104 |
|
NCBI chr X:27,091,780...27,116,092
Ensembl chr X:27,091,778...27,116,549
|
|
G |
Tnnc1 |
troponin C1, slow skeletal and cardiac type |
decreases expression |
EXP |
echimidine results in decreased expression of TNNC1 mRNA |
CTD |
PMID:34185104 |
|
NCBI chr16:6,400,801...6,405,634
Ensembl chr16:6,402,171...6,405,634
|
|
G |
Tnnt2 |
troponin T2, cardiac type |
decreases expression |
EXP |
echimidine results in decreased expression of TNNT2 mRNA |
CTD |
PMID:34185104 |
|
NCBI chr13:47,267,325...47,285,390
Ensembl chr13:47,267,204...47,285,388
|
|
G |
Trim54 |
tripartite motif-containing 54 |
decreases expression |
EXP |
echimidine results in decreased expression of TRIM54 mRNA |
CTD |
PMID:34185104 |
|
NCBI chr 6:25,239,340...25,258,511
Ensembl chr 6:25,239,340...25,258,511
|
|
|
G |
H2ax |
H2A.X variant histone |
increases expression |
ISO |
erucifoline results in increased expression of H2AX protein |
CTD |
PMID:31154085 |
|
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239 Ensembl chr 4:44,671,786...44,673,239
|
|
|
G |
Abcb11 |
ATP binding cassette subfamily B member 11 |
decreases expression |
ISO |
heliotrine results in decreased expression of ABCB11 mRNA |
CTD |
PMID:26100227 |
|
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
|
|
G |
Abcb1b |
ATP-binding cassette, sub-family B member 1B |
increases expression |
EXP |
heliotrine results in increased expression of ABCB1B mRNA |
CTD |
PMID:32419051 |
|
NCBI chr 4:25,242,761...25,325,194
Ensembl chr 4:25,242,798...25,325,199
|
|
G |
Abcc6 |
ATP binding cassette subfamily C member 6 |
decreases expression |
ISO |
heliotrine results in decreased expression of ABCC6 mRNA |
CTD |
PMID:26100227 |
|
NCBI chr 1:96,447,224...96,501,464
Ensembl chr 1:96,447,251...96,501,464
|
|
G |
Acsm3 |
acyl-CoA synthetase medium-chain family member 3 |
decreases expression |
ISO EXP |
heliotrine results in decreased expression of ACSM3 mRNA |
CTD |
PMID:26100227 PMID:32419051 |
|
NCBI chr 1:174,133,260...174,159,966
Ensembl chr 1:174,133,288...174,160,184
|
|
G |
Actg2 |
actin gamma 2, smooth muscle |
decreases expression |
EXP |
heliotrine results in decreased expression of ACTG2 mRNA |
CTD |
PMID:34185104 |
|
NCBI chr 4:116,021,832...116,046,475
Ensembl chr 4:116,021,832...116,046,465
|
|
G |
Actn2 |
actinin alpha 2 |
decreases expression |
EXP |
heliotrine results in decreased expression of ACTN2 mRNA |
CTD |
PMID:34185104 |
|
NCBI chr17:58,143,334...58,210,622
Ensembl chr17:58,142,625...58,210,622
|
|
G |
Adam8 |
ADAM metallopeptidase domain 8 |
increases expression |
EXP |
heliotrine results in increased expression of ADAM8 mRNA |
CTD |
PMID:32419051 |
|
NCBI chr 1:194,776,559...194,789,330
Ensembl chr 1:194,770,060...194,788,801
|
|
G |
Adgre4 |
adhesion G protein-coupled receptor E4 |
increases expression |
EXP |
heliotrine results in increased expression of ADGRE4 mRNA |
CTD |
PMID:34185104 |
|
NCBI chr 9:9,758,106...9,901,908
Ensembl chr 9:9,760,355...9,900,760
|
|
G |
Aff3 |
ALF transcription elongation factor 3 |
decreases expression |
ISO |
heliotrine results in decreased expression of AFF3 mRNA |
CTD |
PMID:26100227 |
|
NCBI chr 9:40,399,099...40,856,716
Ensembl chr 9:40,404,375...40,857,247
|
|
G |
Agxt |
alanine--glyoxylate aminotransferase |
decreases expression |
ISO |
heliotrine results in decreased expression of AGXT mRNA |
CTD |
PMID:26100227 |
|
NCBI chr 9:93,675,384...93,685,337
Ensembl chr 9:93,675,384...93,685,336
|
|
G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
increases expression |
EXP |
heliotrine results in increased expression of ALDH1A1 mRNA |
CTD |
PMID:32419051 |
|
NCBI chr 1:218,000,470...218,152,962
Ensembl chr 1:218,042,127...218,152,961
|
|
G |
Aldh5a1 |
aldehyde dehydrogenase 5 family, member A1 |
decreases expression |
ISO |
heliotrine results in decreased expression of ALDH5A1 mRNA |
CTD |
PMID:26100227 |
|
NCBI chr17:40,132,339...40,158,677
Ensembl chr17:40,130,883...40,158,677
|
|
G |
Aldh6a1 |
aldehyde dehydrogenase 6 family, member A1 |
decreases expression |
ISO |
heliotrine results in decreased expression of ALDH6A1 mRNA |
CTD |
PMID:26100227 |
|
NCBI chr 6:104,077,975...104,098,636
Ensembl chr 6:104,077,979...104,098,656
|
|
G |
Aldh8a1 |
aldehyde dehydrogenase 8 family, member A1 |
decreases expression |
ISO |
heliotrine results in decreased expression of ALDH8A1 mRNA |
CTD |
PMID:26100227 |
|
NCBI chr 1:16,183,940...16,203,385
Ensembl chr 1:16,183,940...16,203,385
|
|
G |
Amz1 |
archaelysin family metallopeptidase 1 |
increases expression |
EXP |
heliotrine results in increased expression of AMZ1 mRNA |
CTD |
PMID:34185104 |
|
NCBI chr12:13,886,518...13,924,275
Ensembl chr12:13,891,123...13,909,783
|
|
G |
Ankrd1 |
ankyrin repeat domain 1 |
decreases expression |
EXP |
heliotrine results in decreased expression of ANKRD1 mRNA |
CTD |
PMID:34185104 |
|
NCBI chr 1:233,815,851...233,834,891
Ensembl chr 1:233,815,851...233,834,919
|
|
G |
Areg |
amphiregulin |
increases expression |
ISO |
heliotrine results in increased expression of AREG mRNA |
CTD |
PMID:26100227 |
|
NCBI chr14:16,972,185...16,981,443
Ensembl chr14:16,972,187...16,981,535
|
|
G |
Atp6v1d |
ATPase H+ transporting V1 subunit D |
increases expression |
EXP |
heliotrine results in increased expression of ATP6V1D mRNA |
CTD |
PMID:32419051 |
|
NCBI chr 6:97,656,725...97,672,295
Ensembl chr 6:97,656,576...97,672,303
|
|
G |
C3ar1 |
complement C3a receptor 1 |
increases expression |
EXP |
heliotrine results in increased expression of C3AR1 mRNA |
CTD |
PMID:34185104 |
|
NCBI chr 4:156,074,747...156,084,680
Ensembl chr 4:156,075,389...156,084,701
|
|
G |
Casp3 |
caspase 3 |
multiple interactions |
ISO |
heliotrine results in increased activity of and results in increased cleavage of CASP3 protein |
CTD |
PMID:29458164 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp8 |
caspase 8 |
increases cleavage |
ISO |
heliotrine results in increased cleavage of CASP8 protein |
CTD |
PMID:29458164 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
increases activity |
ISO |
heliotrine results in increased activity of CASP9 protein |
CTD |
PMID:29458164 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Ccng1 |
cyclin G1 |
increases expression |
EXP |
heliotrine results in increased expression of CCNG1 mRNA |
CTD |
PMID:32419051 |
|
NCBI chr10:25,176,231...25,182,604
Ensembl chr10:25,176,234...25,181,641
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
increases expression |
EXP |
heliotrine results in increased expression of CDKN1A mRNA |
CTD |
PMID:32419051 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Ckap2 |
cytoskeleton associated protein 2 |
increases expression |
EXP |
heliotrine results in increased expression of CKAP2 mRNA |
CTD |
PMID:32419051 |
|
NCBI chr16:69,839,668...69,864,852
Ensembl chr16:69,839,630...69,864,913
|
|
G |
Ckm |
creatine kinase, M-type |
decreases expression |
EXP |
heliotrine results in decreased expression of CKM mRNA |
CTD |
PMID:34185104 |
|
NCBI chr 1:79,061,390...79,071,721
Ensembl chr 1:79,061,456...79,071,720
|
|
G |
Ckmt2 |
creatine kinase, mitochondrial 2 |
decreases expression |
EXP |
heliotrine results in decreased expression of CKMT2 mRNA |
CTD |
PMID:34185104 |
|
NCBI chr 2:23,079,918...23,110,518
Ensembl chr 2:23,079,918...23,110,430
|
|
G |
Clec4a1 |
C-type lectin domain family 4, member A1 |
increases expression |
EXP |
heliotrine results in increased expression of CLEC4A1 mRNA |
CTD |
PMID:34185104 |
|
NCBI chr 4:156,173,894...156,186,009
Ensembl chr 4:156,173,894...156,186,008
|
|
G |
Clec4f |
C-type lectin domain family 4, member F |
decreases expression |
EXP |
heliotrine results in decreased expression of CLEC4F mRNA |
CTD |
PMID:32419051 |
|
NCBI chr 4:116,129,023...116,138,744
Ensembl chr 4:116,129,023...116,138,775
|
|
G |
Cox6a2 |
cytochrome c oxidase subunit 6A2 |
decreases expression |
EXP |
heliotrine results in decreased expression of COX6A2 mRNA |
CTD |
PMID:34185104 |
|
NCBI chr 1:182,788,528...182,790,746
Ensembl chr 1:182,788,528...182,789,274
|
|
G |
Csf1r |
colony stimulating factor 1 receptor |
decreases expression |
EXP |
heliotrine results in decreased expression of CSF1R mRNA |
CTD |
PMID:32419051 |
|
NCBI chr18:54,546,673...54,590,418
Ensembl chr18:54,546,659...54,590,415
|
|
G |
Csrp3 |
cysteine and glycine rich protein 3 |
decreases expression |
EXP |
heliotrine results in decreased expression of CSRP3 mRNA |
CTD |
PMID:34185104 |
|
NCBI chr 1:98,528,067...98,546,647
Ensembl chr 1:98,528,068...98,546,653
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
increases response to substance |
ISO |
CYP3A4 protein results in increased susceptibility to heliotrine |
CTD |
PMID:32910235 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
decreases expression |
ISO |
heliotrine results in decreased expression of CYP3A5 mRNA |
CTD |
PMID:26100227 |
|
NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422
|
|
G |
Cyp4a1 |
cytochrome P450, family 4, subfamily a, polypeptide 1 |
decreases expression |
ISO |
heliotrine results in decreased expression of CYP4A22 mRNA |
CTD |
PMID:26100227 |
|
NCBI chr 5:129,123,323...129,137,464
Ensembl chr 5:129,123,336...129,137,464
|
|
G |
Cyp4f18 |
cytochrome P450, family 4, subfamily f, polypeptide 18 |
decreases expression |
ISO |
heliotrine results in decreased expression of CYP4F3 mRNA |
CTD |
PMID:26100227 |
|
NCBI chr16:17,763,543...17,804,944
Ensembl chr16:17,707,317...17,804,940
|
|
G |
Cyp7a1 |
cytochrome P450 family 7 subfamily A member 1 |
decreases expression |
ISO |
heliotrine results in decreased expression of CYP7A1 mRNA |
CTD |
PMID:26100227 |
|
NCBI chr 5:19,376,979...19,386,676
Ensembl chr 5:19,376,974...19,386,688
|
|
G |
Cyp8b1 |
cytochrome P450 family 8 subfamily B member 1 |
decreases expression |
ISO |
heliotrine results in decreased expression of CYP8B1 mRNA |
CTD |
PMID:26100227 |
|
NCBI chr 8:121,578,123...121,580,093
Ensembl chr 8:121,557,062...121,580,166
|
|
G |
Cyria |
CYFIP related Rac1 interactor A |
increases expression |
EXP |
heliotrine results in increased expression of CYRIA mRNA |
CTD |
PMID:32419051 |
|
NCBI chr 6:35,045,208...35,150,669
Ensembl chr 6:35,045,208...35,150,668
|
|
G |
Ddias |
DNA damage-induced apoptosis suppressor |
increases expression |
EXP |
heliotrine results in increased expression of DDIAS mRNA |
CTD |
PMID:32419051 |
|
NCBI chr 1:146,906,150...146,930,462
Ensembl chr 1:146,906,154...146,930,462
|
|
G |
Dhrs9 |
dehydrogenase/reductase 9 |
increases expression |
ISO |
heliotrine results in increased expression of DHRS9 mRNA |
CTD |
PMID:26100227 |
|
NCBI chr 3:54,147,834...54,170,052
Ensembl chr 3:54,147,803...54,220,241
|
|
G |
Dnase1l3 |
deoxyribonuclease 1L3 |
decreases expression |
EXP |
heliotrine results in decreased expression of DNASE1L3 mRNA |
CTD |
PMID:34185104 |
|
NCBI chr15:16,922,335...16,948,322
Ensembl chr15:16,922,335...16,948,317
|
|
G |
Dpyd |
dihydropyrimidine dehydrogenase |
decreases expression |
ISO |
heliotrine results in decreased expression of DPYD mRNA |
CTD |
PMID:26100227 |
|
NCBI chr 2:206,609,043...207,474,982
Ensembl chr 2:206,609,122...207,474,982
|
|
G |
Eda2r |
ectodysplasin A2 receptor |
increases expression |
EXP |
heliotrine results in increased expression of EDA2R mRNA |
CTD |
PMID:32419051 |
|
NCBI chr X:62,224,763...62,269,333
Ensembl chr X:62,228,229...62,269,268
|
|
G |
Eef1a2 |
eukaryotic translation elongation factor 1 alpha 2 |
decreases expression |
EXP |
heliotrine results in decreased expression of EEF1A2 mRNA |
CTD |
PMID:34185104 |
|
NCBI chr 3:168,265,893...168,275,071
Ensembl chr 3:168,195,357...168,275,071
|
|
G |
Emilin2 |
elastin microfibril interfacer 2 |
increases expression |
EXP |
heliotrine results in increased expression of EMILIN2 mRNA |
CTD |
PMID:34185104 |
|
NCBI chr 9:111,160,708...111,220,463
Ensembl chr 9:111,160,712...111,220,352
|
|
G |
Ephx1 |
epoxide hydrolase 1 |
increases expression |
EXP |
heliotrine results in increased expression of EPHX1 mRNA |
CTD |
PMID:32419051 |
|
NCBI chr13:92,714,315...92,744,105
Ensembl chr13:92,714,315...92,790,235
|
|
G |
Ephx2 |
epoxide hydrolase 2 |
decreases expression |
ISO |
heliotrine results in decreased expression of EPHX2 mRNA |
CTD |
PMID:26100227 |
|
NCBI chr15:40,289,901...40,327,632
Ensembl chr15:40,289,902...40,327,615
|
|
G |
Fas |
Fas cell surface death receptor |
increases expression |
ISO EXP |
heliotrine metabolite results in increased expression of FAS mRNA heliotrine results in increased expression of FAS mRNA |
CTD |
PMID:30465738 PMID:32419051 |
|
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Fcgr3a |
Fc gamma receptor 3A |
increases expression |
EXP |
heliotrine results in increased expression of FCGR3A mRNA |
CTD |
PMID:34185104 |
|
NCBI chr13:83,249,905...83,259,921
Ensembl chr13:83,249,872...83,259,921
|
|
G |
Fmo3 |
flavin containing dimethylaniline monoxygenase 3 |
decreases expression |
ISO |
heliotrine results in decreased expression of FMO3 mRNA |
CTD |
PMID:26100227 |
|
NCBI chr13:75,309,367...75,334,915
Ensembl chr13:75,309,374...75,328,028
|
|
G |
Fmo4 |
flavin containing dimethylaniline monoxygenase 4 |
decreases expression |
ISO |
heliotrine results in decreased expression of FMO4 mRNA |
CTD |
PMID:26100227 |
|
NCBI chr13:75,154,683...75,172,874
Ensembl chr13:75,154,684...75,172,874
|
|
G |
Gamt |
guanidinoacetate N-methyltransferase |
decreases expression |
ISO |
heliotrine results in decreased expression of GAMT mRNA |
CTD |
PMID:26100227 |
|
NCBI chr 7:9,448,590...9,451,413
Ensembl chr 7:9,448,628...9,451,778
|
|
G |
Gem |
GTP binding protein overexpressed in skeletal muscle |
increases expression |
ISO |
heliotrine results in increased expression of GEM mRNA |
CTD |
PMID:26100227 |
|
NCBI chr 5:25,214,309...25,225,222
Ensembl chr 5:25,214,309...25,225,222
|
|
G |
Gls |
glutaminase |
increases expression |
ISO |
heliotrine results in increased expression of GLS mRNA |
CTD |
PMID:26100227 |
|
NCBI chr 9:49,344,616...49,416,900
Ensembl chr 9:49,344,781...49,416,900
|
|
G |
Glyat |
glycine-N-acyltransferase |
decreases expression |
ISO |
heliotrine results in decreased expression of GLYAT mRNA |
CTD |
PMID:26100227 |
|
NCBI chr 1:209,704,213...209,724,949
Ensembl chr 1:209,704,268...209,724,942
|
|
G |
Gnat1 |
G protein subunit alpha transducin 1 |
increases expression |
EXP |
heliotrine results in increased expression of GNAT1 mRNA |
CTD |
PMID:34185104 |
|
NCBI chr 8:108,350,935...108,355,671
Ensembl chr 8:108,350,935...108,355,671
|
|
G |
Gpc1 |
glypican 1 |
decreases expression |
EXP |
heliotrine results in decreased expression of GPC1 mRNA |
CTD |
PMID:34185104 |
|
NCBI chr 9:93,396,234...93,424,047
Ensembl chr 9:93,396,234...93,424,047
|
|
G |
Gphn |
gephyrin |
decreases expression |
ISO |
heliotrine results in decreased expression of GPHN mRNA |
CTD |
PMID:26100227 |
|
NCBI chr 6:96,954,365...97,483,617
Ensembl chr 6:96,892,148...97,483,612
|
|
G |
Gprc5a |
G protein-coupled receptor, class C, group 5, member A |
increases expression |
ISO |
heliotrine results in increased expression of GPRC5A mRNA |
CTD |
PMID:26100227 |
|
NCBI chr 4:167,903,542...167,922,276
Ensembl chr 4:167,903,542...167,922,260
|
|
G |
Gria3 |
glutamate ionotropic receptor AMPA type subunit 3 |
increases expression |
EXP |
heliotrine results in increased expression of GRIA3 mRNA |
CTD |
PMID:32419051 |
|
NCBI chr X:120,238,515...120,504,106
Ensembl chr X:120,238,534...120,504,096
|
|
G |
Grk3 |
G protein-coupled receptor kinase 3 |
increases expression |
EXP |
heliotrine results in increased expression of GRK3 mRNA |
CTD |
PMID:34185104 |
|
NCBI chr12:43,624,778...43,735,375
Ensembl chr12:43,624,897...43,731,262
|
|
G |
H2ax |
H2A.X variant histone |
increases expression |
ISO |
heliotrine results in increased expression of H2AX protein |
CTD |
PMID:31154085 |
|
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239 Ensembl chr 4:44,671,786...44,673,239
|
|
G |
Hjv |
hemojuvelin BMP co-receptor |
decreases expression |
EXP |
heliotrine results in decreased expression of HJV mRNA |
CTD |
PMID:34185104 |
|
NCBI chr 2:184,065,944...184,069,851
Ensembl chr 2:184,065,970...184,069,850
|
|
G |
Hnmt |
histamine N-methyltransferase |
decreases expression |
ISO |
heliotrine results in decreased expression of HNMT mRNA |
CTD |
PMID:26100227 |
|
NCBI chr 3:6,591,804...6,623,821
Ensembl chr 3:6,591,463...6,624,012
|
|
G |
Hrc |
histidine rich calcium binding protein |
decreases expression |
EXP |
heliotrine results in decreased expression of HRC mRNA |
CTD |
PMID:34185104 |
|
NCBI chr 1:95,813,262...95,816,987
Ensembl chr 1:95,813,253...95,816,984
|
|
G |
Hsd17b13 |
hydroxysteroid (17-beta) dehydrogenase 13 |
increases expression |
EXP |
heliotrine results in increased expression of HSD17B13 mRNA |
CTD |
PMID:32419051 |
|
NCBI chr14:5,751,697...5,766,809
Ensembl chr14:5,752,132...5,768,166
|
|
G |
Il17rd |
interleukin 17 receptor D |
increases expression |
EXP |
heliotrine results in increased expression of IL17RD mRNA |
CTD |
PMID:32419051 |
|
NCBI chr16:2,228,438...2,295,122
Ensembl chr16:2,228,287...2,292,556
|
|
G |
Inmt |
indolethylamine N-methyltransferase |
decreases expression |
EXP |
heliotrine results in decreased expression of INMT mRNA |
CTD |
PMID:32419051 |
|
NCBI chr 4:84,318,197...84,322,493
Ensembl chr 4:84,318,197...84,322,493
|
|
G |
Isg20 |
interferon stimulated exonuclease gene 20 |
increases expression |
ISO |
heliotrine results in increased expression of ISG20 mRNA |
CTD |
PMID:26100227 |
|
NCBI chr 1:132,829,303...132,837,027
Ensembl chr 1:132,815,123...132,837,027
|
|
G |
Itgal |
integrin subunit alpha L |
increases expression |
EXP |
heliotrine results in increased expression of ITGAL mRNA |
CTD |
PMID:34185104 |
|
NCBI chr 1:181,918,183...181,955,735
Ensembl chr 1:181,918,183...181,955,732
|
|
G |
Itgb2 |
integrin subunit beta 2 |
increases expression |
EXP |
heliotrine results in increased expression of ITGB2 mRNA |
CTD |
PMID:34185104 |
|
NCBI chr20:11,061,394...11,097,656
Ensembl chr20:11,061,430...11,097,600
|
|
G |
Jam3 |
junctional adhesion molecule 3 |
increases expression |
EXP |
heliotrine results in increased expression of JAM3 mRNA |
CTD |
PMID:32419051 |
|
NCBI chr 8:25,508,461...25,569,306
Ensembl chr 8:25,507,057...25,569,355
|
|
G |
Knl1 |
kinetochore scaffold 1 |
increases expression |
EXP |
heliotrine results in increased expression of KNL1 mRNA |
CTD |
PMID:32419051 |
|
NCBI chr 3:106,029,627...106,091,915
Ensembl chr 3:106,029,661...106,091,915
|
|
G |
Maff |
MAF bZIP transcription factor F |
increases expression |
ISO |
heliotrine results in increased expression of MAFF mRNA |
CTD |
PMID:26100227 |
|
NCBI chr 7:110,912,367...110,923,711
Ensembl chr 7:110,912,499...110,923,851
|
|
G |
Mal |
mal, T-cell differentiation protein |
increases expression |
EXP |
heliotrine results in increased expression of MAL mRNA |
CTD |
PMID:34185104 |
|
NCBI chr 3:114,864,378...114,888,136
Ensembl chr 3:114,864,378...114,888,136
|
|
G |
Maoa |
monoamine oxidase A |
decreases expression |
ISO |
heliotrine results in decreased expression of MAOA mRNA |
CTD |
PMID:26100227 |
|
NCBI chr X:6,032,172...6,098,308
Ensembl chr X:6,030,795...6,099,593
|
|
G |
Maob |
monoamine oxidase B |
decreases expression |
ISO |
heliotrine results in decreased expression of MAOB mRNA |
CTD |
PMID:26100227 |
|
NCBI chr X:5,907,327...6,010,996
Ensembl chr X:5,907,266...6,011,003
|
|
G |
Mastl |
microtubule associated serine/threonine kinase-like |
increases expression |
EXP |
heliotrine results in increased expression of MASTL mRNA |
CTD |
PMID:32419051 |
|
NCBI chr17:85,250,512...85,287,479
Ensembl chr17:85,251,997...85,287,353
|
|
G |
Mb |
myoglobin |
decreases expression |
EXP |
heliotrine results in decreased expression of MB mRNA |
CTD |
PMID:34185104 |
|
NCBI chr 7:108,759,903...108,767,134
Ensembl chr 7:108,759,904...108,767,383
|
|
G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
increases expression |
EXP |
heliotrine results in increased expression of MGMT mRNA |
CTD |
PMID:32419051 |
|
NCBI chr 1:191,710,980...191,937,760
Ensembl chr 1:191,710,930...191,937,756
|
|
G |
Mki67 |
marker of proliferation Ki-67 |
increases expression |
EXP |
heliotrine results in increased expression of MKI67 mRNA |
CTD |
PMID:32419051 |
|
NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762
|
|
G |
Mmp1 |
matrix metallopeptidase 1 |
increases expression |
ISO |
heliotrine results in increased expression of MMP1 mRNA |
CTD |
PMID:26100227 |
|
NCBI chr 8:4,658,588...4,679,099
Ensembl chr 8:4,658,588...4,679,097
|
|
G |
Mok |
MOK protein kinase |
increases expression |
EXP |
heliotrine results in increased expression of MOK mRNA |
CTD |
PMID:32419051 |
|
NCBI chr 6:129,823,794...129,854,669
Ensembl chr 6:129,823,795...129,854,700
|
|
G |
Mybl1 |
MYB proto-oncogene like 1 |
increases expression |
EXP |
heliotrine results in increased expression of MYBL1 mRNA |
CTD |
PMID:32419051 |
|
NCBI chr 5:9,582,905...9,618,179
Ensembl chr 5:9,582,934...9,618,183
|
|
G |
Mybl2 |
MYB proto-oncogene like 2 |
increases expression |
EXP |
heliotrine results in increased expression of MYBL2 mRNA |
CTD |
PMID:32419051 |
|
NCBI chr 3:151,705,254...151,733,714
Ensembl chr 3:151,705,288...151,733,708
|
|
G |
Mybpc3 |
myosin binding protein C3 |
decreases expression |
EXP |
heliotrine results in decreased expression of MYBPC3 mRNA |
CTD |
PMID:34185104 |
|
NCBI chr 3:77,095,165...77,113,406
Ensembl chr 3:77,095,252...77,113,405
|
|
G |
Myh6 |
myosin heavy chain 6 |
decreases expression |
EXP |
heliotrine results in decreased expression of MYH6 mRNA |
CTD |
PMID:34185104 |
|
NCBI chr15:28,418,120...28,442,316
Ensembl chr15:28,417,616...28,441,720
|
|
G |
Myl4 |
myosin, light chain 4 |
decreases expression |
EXP |
heliotrine results in decreased expression of MYL4 mRNA |
CTD |
PMID:34185104 |
|
NCBI chr10:89,449,456...89,485,365
Ensembl chr10:89,449,443...89,485,363
|
|
G |
Myom1 |
myomesin 1 |
decreases expression |
EXP |
heliotrine results in decreased expression of MYOM1 mRNA |
CTD |
PMID:34185104 |
|
NCBI chr 9:110,916,156...111,039,344
Ensembl chr 9:110,915,943...111,039,344
|
|
G |
Myoz2 |
myozenin 2 |
decreases expression |
EXP |
heliotrine results in decreased expression of MYOZ2 mRNA |
CTD |
PMID:34185104 |
|
NCBI chr 2:211,141,463...211,168,187
Ensembl chr 2:211,141,463...211,168,221
|
|
G |
Neb |
nebulin |
decreases expression |
ISO |
heliotrine results in decreased expression of NEB mRNA |
CTD |
PMID:26100227 |
|
NCBI chr 3:36,613,677...36,811,618
Ensembl chr 3:36,613,716...36,811,574
|
|
G |
Nnmt |
nicotinamide N-methyltransferase |
decreases expression |
ISO |
heliotrine results in decreased expression of NNMT mRNA |
CTD |
PMID:26100227 |
|
NCBI chr 8:48,928,663...48,947,734
Ensembl chr 8:48,933,598...48,946,655
|
|
G |
Nrcam |
neuronal cell adhesion molecule |
increases expression |
EXP |
heliotrine results in increased expression of NRCAM mRNA |
CTD |
PMID:32419051 |
|
NCBI chr 6:61,402,813...61,698,536
Ensembl chr 6:61,329,863...61,702,992
|
|
G |
Nrg1 |
neuregulin 1 |
increases expression |
EXP |
heliotrine results in increased expression of NRG1 mRNA |
CTD |
PMID:32419051 |
|
NCBI chr16:59,250,658...60,304,519
Ensembl chr16:59,250,854...60,296,884
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
decreases expression |
ISO |
heliotrine results in decreased expression of PARP1 protein |
CTD |
PMID:29458164 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Pld4 |
phospholipase D family, member 4 |
increases expression |
EXP |
heliotrine results in increased expression of PLD4 mRNA |
CTD |
PMID:34185104 |
|
NCBI chr 6:131,818,860...131,827,457
Ensembl chr 6:131,818,860...131,826,376
|
|
G |
Pln |
phospholamban |
decreases expression |
EXP |
heliotrine results in decreased expression of PLN mRNA |
CTD |
PMID:34185104 |
|
NCBI chr20:32,629,537...32,639,559
|
|
G |
Pstpip2 |
proline-serine-threonine phosphatase-interacting protein 2 |
increases expression |
EXP |
heliotrine results in increased expression of PSTPIP2 mRNA |
CTD |
PMID:34185104 |
|
NCBI chr18:71,310,387...71,396,752
Ensembl chr18:71,311,020...71,395,709
|
|
G |
Ptprd |
protein tyrosine phosphatase, receptor type, D |
decreases expression |
ISO |
heliotrine results in decreased expression of PTPRD mRNA |
CTD |
PMID:26100227 |
|
NCBI chr 5:90,046,993...90,698,977 NCBI chr 5:91,122,354...91,641,754
Ensembl chr 5:90,048,966...92,369,396
|
|
G |
Rapgef4 |
Rap guanine nucleotide exchange factor 4 |
decreases expression |
ISO |
heliotrine results in decreased expression of RAPGEF4 mRNA |
CTD |
PMID:26100227 |
|
NCBI chr 3:56,809,388...57,101,332
Ensembl chr 3:56,809,270...57,102,316
|
|
G |
Rrad |
RRAD, Ras related glycolysis inhibitor and calcium channel regulator |
increases expression |
ISO |
heliotrine results in increased expression of RRAD mRNA |
CTD |
PMID:26100227 |
|
NCBI chr19:354,184...357,424
Ensembl chr19:354,198...357,417
|
|
G |
Samsn1 |
SAM domain, SH3 domain and nuclear localization signals, 1 |
increases expression |
EXP |
heliotrine results in increased expression of SAMSN1 mRNA |
CTD |
PMID:34185104 |
|
NCBI chr11:14,484,523...14,534,900
Ensembl chr11:14,483,893...14,534,900
|
|
G |
Sgcb |
sarcoglycan, beta |
increases expression |
EXP |
heliotrine results in increased expression of SGCB mRNA |
CTD |
PMID:32419051 |
|
NCBI chr14:34,563,614...34,578,614
Ensembl chr14:34,563,608...34,578,583
|
|
G |
Slc10a1 |
solute carrier family 10 member 1 |
decreases expression |
ISO |
heliotrine results in decreased expression of SLC10A1 mRNA |
CTD |
PMID:26100227 |
|
NCBI chr 6:100,613,045...100,626,670
Ensembl chr 6:100,613,045...100,626,670
|
|
G |
Slc13a4 |
solute carrier family 13 member 4 |
increases expression |
EXP |
heliotrine results in increased expression of SLC13A4 mRNA |
CTD |
PMID:34185104 |
|
NCBI chr 4:63,943,369...63,988,852
Ensembl chr 4:63,943,395...63,988,857
|
|
G |
Slc22a25 |
solute carrier family 22, member 25 |
decreases expression |
ISO |
heliotrine results in decreased expression of SLC22A9 mRNA |
CTD |
PMID:26100227 |
|
NCBI chr 1:205,338,698...205,498,486
Ensembl chr 1:205,338,699...205,433,085
|
|
G |
Slc22a7 |
solute carrier family 22 member 7 |
decreases expression |
ISO |
heliotrine results in decreased expression of SLC22A7 mRNA |
CTD |
PMID:26100227 |
|
NCBI chr 9:14,547,073...14,554,354
Ensembl chr 9:14,547,849...14,553,921
|
|
G |
Slc38a7 |
solute carrier family 38, member 7 |
increases expression |
EXP |
heliotrine results in increased expression of SLC38A7 mRNA |
CTD |
PMID:34185104 |
|
NCBI chr19:9,209,203...9,225,472
Ensembl chr19:9,209,257...9,225,454
|
|
G |
Slco2b1 |
solute carrier organic anion transporter family, member 2b1 |
decreases expression |
ISO |
heliotrine results in decreased expression of SLCO2B1 mRNA |
CTD |
PMID:26100227 |
|
NCBI chr 1:153,959,288...154,007,294
Ensembl chr 1:153,959,293...154,007,353
|
|
G |
Sln |
sarcolipin |
decreases expression |
EXP |
heliotrine results in decreased expression of SLN mRNA |
CTD |
PMID:34185104 |
|
NCBI chr 8:54,221,389...54,248,110
Ensembl chr 8:54,243,542...54,247,791
|
|
G |
Smpx |
small muscle protein, X-linked |
decreases expression |
EXP |
heliotrine results in decreased expression of SMPX mRNA |
CTD |
PMID:34185104 |
|
NCBI chr X:37,233,209...37,292,266
Ensembl chr X:37,234,294...37,276,708
|
|
G |
Srl |
sarcalumenin |
decreases expression |
EXP |
heliotrine results in decreased expression of SRL mRNA |
CTD |
PMID:34185104 |
|
NCBI chr10:11,033,976...11,078,103
Ensembl chr10:11,034,035...11,078,101
|
|
G |
Stac3 |
SH3 and cysteine rich domain 3 |
decreases expression |
EXP |
heliotrine results in decreased expression of STAC3 mRNA |
CTD |
PMID:32419051 |
|
NCBI chr 7:63,343,078...63,350,590
Ensembl chr 7:63,343,186...63,350,589
|
|
G |
Stc1 |
stanniocalcin 1 |
increases expression |
EXP |
heliotrine results in increased expression of STC1 mRNA |
CTD |
PMID:34185104 |
|
NCBI chr15:44,299,591...44,311,695
Ensembl chr15:44,299,621...44,310,264
|
|
G |
Steap4 |
STEAP4 metalloreductase |
increases expression |
EXP |
heliotrine results in increased expression of STEAP4 mRNA |
CTD |
PMID:34185104 |
|
NCBI chr 4:26,077,182...26,099,859
Ensembl chr 4:26,054,671...26,099,859
|
|
G |
Sult1e1 |
sulfotransferase family 1E member 1 |
decreases expression |
ISO |
heliotrine results in decreased expression of SULT1E1 mRNA |
CTD |
PMID:26100227 |
|
NCBI chr14:20,422,324...20,439,562
Ensembl chr14:20,422,324...20,439,275
|
|
G |
Sult2a1 |
sulfotransferase family 2A member 1 |
decreases expression |
ISO |
heliotrine results in decreased expression of SULT2A1 mRNA |
CTD |
PMID:26100227 |
|
NCBI chr 1:75,451,178...75,508,113
Ensembl chr 1:74,911,100...75,508,134
|
|
G |
Tenm1 |
teneurin transmembrane protein 1 |
decreases expression |
ISO |
heliotrine results in decreased expression of TENM1 mRNA |
CTD |
PMID:26100227 |
|
NCBI chr X:121,400,466...122,289,877
Ensembl chr X:121,403,649...122,290,207
|
|
G |
Tenm2 |
teneurin transmembrane protein 2 |
decreases expression |
ISO |
heliotrine results in decreased expression of TENM2 mRNA |
CTD |
PMID:26100227 |
|
NCBI chr10:20,480,662...21,706,415
Ensembl chr10:20,481,854...21,705,597
|
|
G |
Tlr7 |
toll-like receptor 7 |
increases expression |
EXP |
heliotrine results in increased expression of TLR7 mRNA |
CTD |
PMID:34185104 |
|
NCBI chr X:27,027,380...27,054,309
Ensembl chr X:27,027,425...27,054,754
|
|
G |
Tlr8 |
toll-like receptor 8 |
increases expression |
EXP |
heliotrine results in increased expression of TLR8 mRNA |
CTD |
PMID:34185104 |
|
NCBI chr X:27,091,780...27,116,092
Ensembl chr X:27,091,778...27,116,549
|
|
G |
Tnfrsf1b |
TNF receptor superfamily member 1B |
increases expression |
EXP |
heliotrine results in increased expression of TNFRSF1B mRNA |
CTD |
PMID:34185104 |
|
NCBI chr 5:157,070,642...157,104,216
Ensembl chr 5:157,070,642...157,104,206
|
|
G |
Tnnc1 |
troponin C1, slow skeletal and cardiac type |
decreases expression |
EXP |
heliotrine results in decreased expression of TNNC1 mRNA |
CTD |
PMID:34185104 |
|
NCBI chr16:6,400,801...6,405,634
Ensembl chr16:6,402,171...6,405,634
|
|
G |
Tnnt2 |
troponin T2, cardiac type |
decreases expression |
EXP |
heliotrine results in decreased expression of TNNT2 mRNA |
CTD |
PMID:34185104 |
|
NCBI chr13:47,267,325...47,285,390
Ensembl chr13:47,267,204...47,285,388
|
|
G |
Top2a |
DNA topoisomerase II alpha |
increases expression |
EXP |
heliotrine results in increased expression of TOP2A mRNA |
CTD |
PMID:32419051 |
|
NCBI chr10:83,945,731...83,976,874
Ensembl chr10:83,945,735...83,976,874
|
|
G |
Treml4 |
triggering receptor expressed on myeloid cells-like 4 |
increases expression |
EXP |
heliotrine results in increased expression of TREML4 mRNA |
CTD |
PMID:34185104 |
|
NCBI chr 9:12,718,968...12,743,879
Ensembl chr 9:12,721,815...12,743,253
|
|
G |
Trim54 |
tripartite motif-containing 54 |
decreases expression |
EXP |
heliotrine results in decreased expression of TRIM54 mRNA |
CTD |
PMID:34185104 |
|
NCBI chr 6:25,239,340...25,258,511
Ensembl chr 6:25,239,340...25,258,511
|
|
G |
Tyms |
thymidylate synthetase |
increases expression |
EXP |
heliotrine results in increased expression of TYMS mRNA |
CTD |
PMID:32419051 |
|
NCBI chr 9:113,313,454...113,329,551
Ensembl chr 9:113,313,452...113,329,536
|
|
G |
Ugt3a1 |
UDP glycosyltransferase family 3 member A1 |
decreases expression |
ISO |
heliotrine results in decreased expression of UGT3A1 mRNA |
CTD |
PMID:26100227 |
|
NCBI chr 2:58,327,058...58,350,186
Ensembl chr 2:58,334,603...58,350,186
|
|
G |
Vps13b |
vacuolar protein sorting 13 homolog B |
decreases expression |
ISO |
heliotrine results in decreased expression of VPS13B mRNA |
CTD |
PMID:26100227 |
|
NCBI chr 7:66,557,862...67,128,429
Ensembl chr 7:66,558,471...67,128,429
|
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
increases metabolic processing increases response to substance |
ISO |
CYP3A4 protein results in increased metabolism of indicine CYP3A4 protein results in increased susceptibility to indicine |
CTD |
PMID:32910235 PMID:33884520 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
H2ax |
H2A.X variant histone |
increases expression |
ISO |
indicine analog results in increased expression of H2AX protein |
CTD |
PMID:31154085 |
|
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239 Ensembl chr 4:44,671,786...44,673,239
|
|
|
G |
H2ax |
H2A.X variant histone |
increases expression |
ISO |
intermedine analog results in increased expression of H2AX protein |
CTD |
PMID:31154085 |
|
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239 Ensembl chr 4:44,671,786...44,673,239
|
|
|
G |
H2ax |
H2A.X variant histone |
increases expression |
ISO |
jacobine analog results in increased expression of H2AX protein; jacobine results in increased expression of H2AX protein |
CTD |
PMID:31154085 |
|
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239 Ensembl chr 4:44,671,786...44,673,239
|
|
|
G |
Cxcl1 |
C-X-C motif chemokine ligand 1 |
decreases expression |
EXP |
Ketorolac results in decreased expression of CXCL1 mRNA |
CTD |
PMID:19620882 |
|
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
|
|
G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
multiple interactions |
ISO |
Ketorolac inhibits the reaction [IL4 results in increased expression of CYSLTR1 mRNA] |
CTD |
PMID:19767084 |
|
NCBI chr X:71,661,421...71,690,012
Ensembl chr X:71,663,821...71,690,121
|
|
G |
Ddx3x |
DEAD-box helicase 3, X-linked |
decreases expression |
ISO |
ketorolac decreases expression of DDX3X protein in oral epithelium |
RGD |
PMID:25918862 |
RGD:151356506 |
NCBI chr X:9,479,532...9,493,169
Ensembl chr X:9,479,532...9,493,168
|
|
G |
Epas1 |
endothelial PAS domain protein 1 |
decreases expression |
ISO |
Ketorolac results in decreased expression of EPAS1 protein |
CTD |
PMID:12912967 |
|
NCBI chr 6:7,790,236...7,871,717
Ensembl chr 6:7,790,647...7,871,228
|
|
G |
Fcer1a |
Fc epsilon receptor Ia |
multiple interactions |
ISO |
Ketorolac inhibits the reaction [IL4 results in increased expression of FCER1A mRNA] |
CTD |
PMID:19767084 |
|
NCBI chr13:85,686,099...85,692,394
Ensembl chr13:85,686,092...85,692,351
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
EXP |
Ketorolac inhibits the reaction [IL1B protein results in increased expression of FOS mRNA] |
CTD |
PMID:10800959 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
decreases expression |
ISO |
Ketorolac results in decreased expression of HIF1A protein |
CTD |
PMID:12912967 |
|
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
decreases expression |
EXP |
Ketorolac results in decreased expression of ICAM1 mRNA |
CTD |
PMID:19620882 |
|
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
EXP |
[Ketorolac co-treated with IL1B protein] results in increased secretion of Dinoprostone; Ketorolac inhibits the reaction [IL1B protein results in increased expression of FOS mRNA]; Ketorolac inhibits the reaction [IL1B protein results in increased expression of NR4A1 mRNA]; Ketorolac inhibits the reaction [IL1B protein results in increased expression of PTGER4 mRNA]; Ketorolac inhibits the reaction [IL1B protein results in increased secretion of Corticosterone] |
CTD |
PMID:10800959 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il4 |
interleukin 4 |
multiple interactions |
ISO |
Ketorolac inhibits the reaction [IL4 results in increased activity of STAT6 protein]; Ketorolac inhibits the reaction [IL4 results in increased expression of CYSLTR1 mRNA]; Ketorolac inhibits the reaction [IL4 results in increased expression of FCER1A mRNA]; Ketorolac inhibits the reaction [IL4 results in increased phosphorylation of STAT6 protein] |
CTD |
PMID:19767084 |
|
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
|
|
G |
Mpo |
myeloperoxidase |
decreases activity |
EXP |
Ketorolac results in decreased activity of MPO |
CTD |
PMID:11996850 |
|
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
|
|
G |
Nr4a1 |
nuclear receptor subfamily 4, group A, member 1 |
multiple interactions |
EXP |
Ketorolac inhibits the reaction [IL1B protein results in increased expression of NR4A1 mRNA] |
CTD |
PMID:10800959 |
|
NCBI chr 7:132,368,399...132,389,300
Ensembl chr 7:132,374,840...132,389,297
|
|
G |
Ptger4 |
prostaglandin E receptor 4 |
multiple interactions |
EXP |
Ketorolac inhibits the reaction [IL1B protein results in increased expression of PTGER4 mRNA] |
CTD |
PMID:10800959 |
|
NCBI chr 2:54,330,563...54,347,451
Ensembl chr 2:54,335,424...54,346,670
|
|
G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
decreases expression decreases activity |
ISO |
Ketorolac results in decreased expression of PTGS1 mRNA Ketorolac results in decreased activity of PTGS1 protein |
CTD |
PMID:17175104 |
|
NCBI chr 3:19,584,015...19,605,589
Ensembl chr 3:19,584,015...19,605,586
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
increases expression multiple interactions decreases expression |
ISO EXP |
Ketorolac results in increased expression of PTGS2 mRNA Ketorolac inhibits the reaction [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide promotes the reaction [Carrageenan results in increased expression of PTGS2 protein]] Ketorolac results in decreased expression of PTGS2 mRNA |
CTD |
PMID:17175104 PMID:17258197 PMID:19620882 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
RT1-A2 |
RT1 class Ia, locus A2 |
affects expression |
ISO |
Ketorolac affects the expression of HLA-E mRNA |
CTD |
PMID:25811541 |
|
NCBI chr20:4,870,939...4,910,183
|
|
G |
RT1-CE16 |
RT1 class I, locus CE16 |
affects expression |
ISO |
Ketorolac affects the expression of HLA-A mRNA |
CTD |
PMID:25811541 |
|
NCBI chr20:3,257,109...3,260,747
Ensembl chr20:3,257,123...3,279,563
|
|
G |
RT1-M3-1 |
RT1 class Ib, locus M3, gene 1 |
affects expression |
ISO |
Ketorolac affects the expression of HLA-G mRNA |
CTD |
PMID:25811541 |
|
NCBI chr20:1,323,976...1,328,126
Ensembl chr20:1,287,521...1,328,117
|
|
G |
Sele |
selectin E |
decreases expression |
EXP |
Ketorolac results in decreased expression of SELE mRNA |
CTD |
PMID:19620882 |
|
NCBI chr13:76,402,841...76,412,741
Ensembl chr13:76,403,304...76,412,741
|
|
G |
Stat6 |
signal transducer and activator of transcription 6 |
multiple interactions |
ISO |
Ketorolac inhibits the reaction [IL4 results in increased activity of STAT6 protein]; Ketorolac inhibits the reaction [IL4 results in increased phosphorylation of STAT6 protein] |
CTD |
PMID:19767084 |
|
NCBI chr 7:63,480,229...63,497,551
Ensembl chr 7:63,479,642...63,498,495
|
|
G |
Ugt2b7 |
UDP glucuronosyltransferase family 2 member B7 |
multiple interactions |
ISO |
Ketorolac inhibits the reaction [UGT2B7 protein results in increased chemical synthesis of aldosterone 18-glucuronide]; Ketorolac inhibits the reaction [UGT2B7 protein results in increased glucuronidation of Aldosterone] |
CTD |
PMID:19740398 |
|
NCBI chr14:20,896,682...20,919,604
Ensembl chr14:20,896,682...20,919,604
|
|
|
G |
Abcb11 |
ATP binding cassette subfamily B member 11 |
decreases expression |
ISO |
lasiocarpine results in decreased expression of ABCB11 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
|
|
G |
Abcb1b |
ATP-binding cassette, sub-family B member 1B |
increases expression |
EXP |
lasiocarpine results in increased expression of ABCB1B mRNA |
CTD |
PMID:32419051 |
|
NCBI chr 4:25,242,761...25,325,194
Ensembl chr 4:25,242,798...25,325,199
|
|
G |
Ace |
angiotensin I converting enzyme |
decreases expression |
ISO |
lasiocarpine metabolite results in decreased expression of ACE mRNA |
CTD |
PMID:30465738 |
|
NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131
|
|
G |
Adam8 |
ADAM metallopeptidase domain 8 |
increases expression |
EXP |
lasiocarpine results in increased expression of ADAM8 mRNA |
CTD |
PMID:32419051 |
|
NCBI chr 1:194,776,559...194,789,330
Ensembl chr 1:194,770,060...194,788,801
|
|
G |
Adgrg1 |
adhesion G protein-coupled receptor G1 |
increases expression |
ISO |
lasiocarpine results in increased expression of ADGRG1 mRNA |
CTD |
PMID:32234424 PMID:35690182 |
|
NCBI chr19:10,003,963...10,041,122
Ensembl chr19:10,003,975...10,041,108
|
|
G |
Adh4 |
alcohol dehydrogenase 4 (class II), pi polypeptide |
decreases expression |
ISO |
lasiocarpine results in decreased expression of ADH4 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:226,948,717...226,966,747
Ensembl chr 2:226,947,466...226,987,591
|
|
G |
Akap5 |
A-kinase anchoring protein 5 |
increases expression |
ISO |
lasiocarpine results in increased expression of AKAP5 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 6:95,051,527...95,061,075
Ensembl chr 6:95,051,537...95,061,578
|
|
G |
Akr1d1 |
aldo-keto reductase family 1, member D1 |
decreases expression |
ISO |
lasiocarpine results in decreased expression of AKR1D1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:66,154,246...66,187,505
Ensembl chr 4:66,154,248...66,186,372
|
|
G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
increases expression |
EXP |
lasiocarpine results in increased expression of ALDH1A1 mRNA |
CTD |
PMID:32419051 |
|
NCBI chr 1:218,000,470...218,152,962
Ensembl chr 1:218,042,127...218,152,961
|
|
G |
Alpi |
alkaline phosphatase, intestinal |
decreases expression |
ISO |
lasiocarpine results in decreased expression of ALPI mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 9:87,773,411...87,776,877
Ensembl chr 9:87,773,411...87,776,877
|
|
G |
Anapc1 |
anaphase promoting complex subunit 1 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of ANAPC1 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 3:115,850,117...115,930,259
Ensembl chr 3:115,850,185...115,930,273
|
|
G |
Anapc11 |
anaphase promoting complex subunit 11 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in increased expression of ANAPC11 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr10:105,875,209...105,886,307
|
|
G |
Anapc2 |
anaphase promoting complex subunit 2 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of ANAPC2 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 3:8,086,434...8,098,182
Ensembl chr 3:8,086,462...8,098,178
|
|
G |
Angpt1 |
angiopoietin 1 |
decreases expression |
ISO |
lasiocarpine metabolite results in decreased expression of ANGPT1 mRNA |
CTD |
PMID:30465738 |
|
NCBI chr 7:73,528,345...73,783,953
Ensembl chr 7:73,531,486...73,784,067
|
|
G |
Arg1 |
arginase 1 |
decreases expression |
ISO |
lasiocarpine results in decreased expression of ARG1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:20,475,878...20,488,422
Ensembl chr 1:20,475,968...20,488,422
|
|
G |
Arid1a |
AT-rich interaction domain 1A |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of ARID1A mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 5:145,908,173...145,981,552
Ensembl chr 5:145,908,181...145,985,564
|
|
G |
Arid2 |
AT-rich interaction domain 2 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of ARID2 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 7:127,447,192...127,565,987
Ensembl chr 7:127,447,278...127,563,512
|
|
G |
Arl14 |
ARF like GTPase 14 |
increases expression |
ISO |
lasiocarpine results in increased expression of ARL14 mRNA |
CTD |
PMID:32234424 PMID:35690182 |
|
NCBI chr 2:153,468,863...153,470,102
Ensembl chr 2:153,468,977...153,469,555
|
|
G |
Aspdh |
aspartate dehydrogenase domain containing |
decreases expression |
ISO |
lasiocarpine results in decreased expression of ASPDH mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:94,956,327...94,960,722
Ensembl chr 1:94,958,316...94,960,722
|
|
G |
Asprv1 |
aspartic peptidase, retroviral-like 1 |
decreases expression |
ISO |
lasiocarpine results in decreased expression of ASPRV1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:119,077,415...119,078,887
Ensembl chr 4:119,077,356...119,078,379
|
|
G |
Atm |
ATM serine/threonine kinase |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of ATM mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 8:53,828,741...53,932,773
Ensembl chr 8:53,831,093...53,932,437
|
|
G |
Aunip |
aurora kinase A and ninein interacting protein |
increases expression |
ISO |
lasiocarpine results in increased expression of AUNIP mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:146,722,329...146,734,924
Ensembl chr 5:146,722,337...146,736,501
|
|
G |
Aurka |
aurora kinase A |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of AURKA mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 3:161,128,309...161,144,524
Ensembl chr 3:161,128,313...161,144,390
|
|
G |
Axl |
Axl receptor tyrosine kinase |
decreases expression |
EXP |
lasiocarpine results in decreased expression of AXL mRNA |
CTD |
PMID:32419051 |
|
NCBI chr 1:81,265,088...81,296,278
Ensembl chr 1:81,265,088...81,296,265
|
|
G |
Babam2 |
BRISC and BRCA1 A complex member 2 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in increased expression of BABAM2 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 6:24,369,021...24,788,416
Ensembl chr 6:24,369,022...24,833,951
|
|
G |
Bard1 |
BRCA1 associated RING domain 1 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of BARD1 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 9:72,616,070...72,694,553
Ensembl chr 9:72,623,155...72,694,265
|
|
G |
Bdh1 |
3-hydroxybutyrate dehydrogenase 1 |
decreases expression |
ISO |
lasiocarpine results in decreased expression of BDH1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr11:69,302,534...69,343,173
Ensembl chr11:69,302,534...69,337,671
|
|
G |
Blm |
BLM RecQ like helicase |
increases expression multiple interactions |
ISO |
lasiocarpine results in increased expression of BLM mRNA [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of BLM mRNA |
CTD |
PMID:32234424 PMID:33884520 |
|
NCBI chr 1:134,409,832...134,496,073
Ensembl chr 1:134,409,857...134,484,312
|
|
G |
Bora |
bora, aurora kinase A activator |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of BORA mRNA |
CTD |
PMID:33884520 |
|
NCBI chr15:75,797,624...75,835,599
Ensembl chr15:75,797,891...75,821,322
|
|
G |
Brca1 |
BRCA1, DNA repair associated |
increases expression multiple interactions |
ISO |
lasiocarpine results in increased expression of BRCA1 mRNA [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of BRCA1 mRNA |
CTD |
PMID:32234424 PMID:33884520 |
|
NCBI chr10:86,417,441...86,477,762
Ensembl chr10:86,418,000...86,477,304
|
|
G |
Brca2 |
BRCA2, DNA repair associated |
increases expression multiple interactions |
ISO |
lasiocarpine results in increased expression of BRCA2 mRNA [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of BRCA2 mRNA |
CTD |
PMID:32234424 PMID:33884520 |
|
NCBI chr12:59,492...103,789
Ensembl chr12:59,819...100,567
|
|
G |
Brd7 |
bromodomain containing 7 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of BRD7 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr19:18,708,792...18,737,497
Ensembl chr19:18,709,022...18,737,494
|
|
G |
Brip1 |
BRCA1 interacting DNA helicase 1 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of BRIP1 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr10:70,907,266...71,031,502
Ensembl chr10:70,907,371...71,030,324
|
|
G |
Capn1 |
calpain 1 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in increased expression of CAPN1 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 1:203,275,912...203,300,848
Ensembl chr 1:203,277,344...203,300,177
|
|
G |
Casp16 |
caspase 16 |
decreases expression |
ISO |
lasiocarpine results in decreased expression of CASP16P mRNA |
CTD |
PMID:32234424 |
|
NCBI chr10:12,586,009...12,592,023
Ensembl chr10:12,586,729...12,589,053 Ensembl chr10:12,586,729...12,589,053
|
|
G |
Ccdc152 |
coiled-coil domain containing 152 |
increases expression |
ISO |
lasiocarpine results in increased expression of CCDC152 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:52,507,987...52,532,880
Ensembl chr 2:52,507,981...52,532,826
|
|
G |
Ccnb1 |
cyclin B1 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of CCNB1 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Ccnb2 |
cyclin B2 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of CCNB2 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 8:71,087,594...71,100,794
Ensembl chr 8:71,087,595...71,100,874
|
|
G |
Ccne2 |
cyclin E2 |
increases expression |
ISO |
lasiocarpine results in increased expression of CCNE2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:24,285,078...24,298,258
Ensembl chr 5:24,284,922...24,297,632
|
|
G |
Ccng1 |
cyclin G1 |
increases expression |
EXP |
lasiocarpine results in increased expression of CCNG1 mRNA |
CTD |
PMID:32419051 |
|
NCBI chr10:25,176,231...25,182,604
Ensembl chr10:25,176,234...25,181,641
|
|
G |
Cd83 |
CD83 molecule |
increases expression |
ISO |
lasiocarpine results in increased expression of CD83 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr17:20,887,309...20,907,009
Ensembl chr17:20,887,309...20,907,083
|
|
G |
Cdc16 |
cell division cycle 16 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of CDC16 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr16:75,773,026...75,796,586
Ensembl chr16:75,773,028...75,796,550
|
|
G |
Cdc20 |
cell division cycle 20 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of CDC20 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 5:131,966,203...131,970,406
Ensembl chr 5:131,966,215...131,970,512
|
|
G |
Cdc23 |
cell division cycle 23 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in increased expression of CDC23 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr18:26,236,891...26,260,611
Ensembl chr18:26,236,890...26,291,163
|
|
G |
Cdc25a |
cell division cycle 25A |
increases expression multiple interactions |
ISO |
lasiocarpine results in increased expression of CDC25A mRNA [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of CDC25A mRNA |
CTD |
PMID:32234424 PMID:33884520 |
|
NCBI chr 8:109,864,356...109,882,734
Ensembl chr 8:109,864,478...109,882,701
|
|
G |
Cdc25b |
cell division cycle 25B |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of CDC25B mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 3:118,407,127...118,417,272
Ensembl chr 3:118,407,128...118,417,272
|
|
G |
Cdc25c |
cell division cycle 25C |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of CDC25C mRNA |
CTD |
PMID:33884520 |
|
NCBI chr18:26,335,156...26,356,199
Ensembl chr18:26,335,834...26,356,185
|
|
G |
Cdc42bpg |
CDC42 binding protein kinase gamma |
increases expression |
ISO |
lasiocarpine results in increased expression of CDC42BPG mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:203,608,339...203,628,502
Ensembl chr 1:203,608,574...203,628,502
|
|
G |
Cdc45 |
cell division cycle 45 |
increases expression |
ISO |
lasiocarpine results in increased expression of CDC45 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr11:82,185,427...82,210,630
Ensembl chr11:82,185,473...82,210,619
|
|
G |
Cdc6 |
cell division cycle 6 |
increases expression |
ISO |
lasiocarpine results in increased expression of CDC6 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr10:83,864,189...83,878,011
Ensembl chr10:83,864,638...83,878,011
|
|
G |
Cdc7 |
cell division cycle 7 |
increases expression multiple interactions |
ISO |
lasiocarpine results in increased expression of CDC7 mRNA [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of CDC7 mRNA |
CTD |
PMID:32234424 PMID:33884520 |
|
NCBI chr14:2,804,660...2,824,796
Ensembl chr14:2,804,661...2,824,778
|
|
G |
Cdk1 |
cyclin-dependent kinase 1 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of CDK1 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
|
|
G |
Cdk2 |
cyclin dependent kinase 2 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of CDK2 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
increases expression multiple interactions |
EXP ISO |
lasiocarpine results in increased expression of CDKN1A mRNA [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in increased expression of CDKN1A mRNA |
CTD |
PMID:32419051 PMID:33884520 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdt1 |
chromatin licensing and DNA replication factor 1 |
increases expression |
ISO |
lasiocarpine results in increased expression of CDT1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr19:50,620,713...50,625,659
Ensembl chr19:50,620,713...50,625,659
|
|
G |
Cel |
carboxyl ester lipase |
increases expression |
ISO |
lasiocarpine results in increased expression of CEL mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 3:11,883,532...11,891,035
Ensembl chr 3:11,883,532...11,891,035
|
|
G |
Chek1 |
checkpoint kinase 1 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of CHEK1 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 8:36,420,565...36,443,477
Ensembl chr 8:36,420,569...36,441,009
|
|
G |
Cldn14 |
claudin 14 |
decreases expression |
ISO |
lasiocarpine results in decreased expression of CLDN14 mRNA |
CTD |
PMID:32234424 PMID:35690182 |
|
NCBI chr11:33,232,281...33,329,440
Ensembl chr11:33,232,220...33,329,171
|
|
G |
Clec4f |
C-type lectin domain family 4, member F |
decreases expression |
EXP |
lasiocarpine results in decreased expression of CLEC4F mRNA |
CTD |
PMID:32419051 |
|
NCBI chr 4:116,129,023...116,138,744
Ensembl chr 4:116,129,023...116,138,775
|
|
G |
Clspn |
claspin |
increases expression multiple interactions |
ISO |
lasiocarpine results in increased expression of CLSPN mRNA [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of CLSPN mRNA |
CTD |
PMID:32234424 PMID:33884520 |
|
NCBI chr 5:138,850,119...138,885,037
Ensembl chr 5:138,850,128...138,885,034
|
|
G |
Col5a2 |
collagen type V alpha 2 chain |
decreases expression |
ISO |
lasiocarpine results in decreased expression of COL5A2 mRNA |
CTD |
PMID:32234424 PMID:35690182 |
|
NCBI chr 9:47,448,741...47,598,134
Ensembl chr 9:47,448,736...47,598,154
|
|
G |
Crppa |
CDP-L-ribitol pyrophosphorylase A |
decreases expression |
ISO |
lasiocarpine results in decreased expression of CRPPA mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 6:53,120,264...53,397,030
Ensembl chr 6:53,121,438...53,397,028
|
|
G |
Csf1r |
colony stimulating factor 1 receptor |
decreases expression |
EXP |
lasiocarpine results in decreased expression of CSF1R mRNA |
CTD |
PMID:32419051 |
|
NCBI chr18:54,546,673...54,590,418
Ensembl chr18:54,546,659...54,590,415
|
|
G |
Cyba |
cytochrome b-245 alpha chain |
decreases expression |
ISO |
lasiocarpine results in decreased expression of CYBA mRNA |
CTD |
PMID:32234424 PMID:35690182 |
|
NCBI chr19:50,487,598...50,495,669
Ensembl chr19:50,487,597...50,495,721
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
increases expression |
ISO |
lasiocarpine results in increased expression of CYP1A1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp2a3 |
cytochrome P450, family 2, subfamily a, polypeptide 3 |
decreases expression |
ISO |
lasiocarpine results in decreased expression of CYP2A7 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:82,171,914...82,179,980
Ensembl chr 1:82,169,949...82,179,979
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
decreases expression |
ISO |
lasiocarpine results in decreased expression of CYP2E1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
increases metabolic processing increases response to substance multiple interactions |
EXP ISO |
CYP3A2 protein results in increased metabolism of lasiocarpine CYP3A4 protein results in increased susceptibility to lasiocarpine CYP3A4 protein results in increased metabolism of lasiocarpine [CYP3A4 protein results in increased metabolism of lasiocarpine] which affects the expression of KIF23 mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of ANAPC1 mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of ANAPC2 mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of ARID1A mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of ARID2 mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of ATM mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of ATRIP mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of AURKA mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of BARD1 mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of BLM mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of BORA mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of BRCA1 mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of BRCA2 mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of BRD7 mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of BRIP1 mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of CCNB1 mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of CCNB2 mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of CDC16 mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of CDC20 mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of CDC25A mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of CDC25B mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of CDC25C mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of CDC7 mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of CDK1 mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of CDK2 mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of CHEK1 mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of CLSPN mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of E2F1 mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of E2F3 mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of E2F5 mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of E2F8 mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of ESPL1 mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of FANCA mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of FANCB mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of FANCD2 mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of FBXO5 mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of HLTF mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of KIF11 mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of MLH1 mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of MRE11 mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of MSH2 mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of MSH6 mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of PHF10 mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of PLK1 mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of PLK4 mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of POU2F1 mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of PPP2R5D mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of PRC1 mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of PTTG1 mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of RAD1 mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of RAD17 mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of RAD21 mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of RBBP8 mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of RBL1 mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of RFC1 mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of RFC2 mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of RFC3 mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of RFC4 mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of RFC5 mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of RPA1 mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of SLC19A1 mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of SMARCC1 mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of SMC1A mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of SMC3 mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of STAG2 mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of TLK1 mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of TOP2A mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of TOPBP1 mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of WEE1 mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in increased expression of ANAPC11 mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in increased expression of BABAM2 mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in increased expression of CAPN1 mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in increased expression of CDC23 mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in increased expression of CDKN1A mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in increased expression of E2F7 mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in increased expression of GADD45A mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in increased expression of PLK2 mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in increased expression of PLK3 mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in increased expression of PPP2CB mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in increased expression of STAT1 mRNA; [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in increased phosphorylation of H2AX protein |
CTD |
PMID:31103741 PMID:32910235 PMID:33884520 PMID:35882637 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Cyp3a23-3a1 |
cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1 |
increases metabolic processing |
EXP |
CYP3A23-3A1 protein results in increased metabolism of lasiocarpine |
CTD |
PMID:31103741 |
|
NCBI chr12:9,256,159...9,285,020
Ensembl chr12:9,254,475...9,285,030 Ensembl chr12:9,254,475...9,285,030
|
|
G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
increases metabolic processing |
ISO |
CYP3A5 protein results in increased metabolism of lasiocarpine |
CTD |
PMID:31103741 |
|
NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422
|
|
G |
Cyp7a1 |
cytochrome P450 family 7 subfamily A member 1 |
decreases expression |
ISO |
lasiocarpine results in decreased expression of CYP7A1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:19,376,979...19,386,676
Ensembl chr 5:19,376,974...19,386,688
|
|
G |
Cyria |
CYFIP related Rac1 interactor A |
increases expression |
EXP |
lasiocarpine results in increased expression of CYRIA mRNA |
CTD |
PMID:32419051 |
|
NCBI chr 6:35,045,208...35,150,669
Ensembl chr 6:35,045,208...35,150,668
|
|
G |
Dscc1 |
DNA replication and sister chromatid cohesion 1 |
increases expression |
ISO |
lasiocarpine results in increased expression of DSCC1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 7:86,482,588...86,498,212
Ensembl chr 7:86,482,588...86,498,212
|
|
G |
Dtl |
denticleless E3 ubiquitin protein ligase homolog |
increases expression |
ISO |
lasiocarpine results in increased expression of DTL mRNA |
CTD |
PMID:32234424 |
|
NCBI chr13:103,115,810...103,155,029
Ensembl chr13:103,117,186...103,154,890
|
|
G |
E2f1 |
E2F transcription factor 1 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of E2F1 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 3:143,064,535...143,075,362
Ensembl chr 3:143,049,478...143,075,361
|
|
G |
E2f2 |
E2F transcription factor 2 |
increases expression |
ISO |
lasiocarpine results in increased expression of E2F2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:148,399,193...148,422,595
Ensembl chr 5:148,399,642...148,421,217
|
|
G |
E2f3 |
E2F transcription factor 3 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of E2F3 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr17:34,601,756...34,679,139
Ensembl chr17:34,601,830...34,676,253
|
|
G |
E2f5 |
E2F transcription factor 5 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of E2F5 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 2:86,997,331...87,012,908
Ensembl chr 2:86,997,332...87,012,990
|
|
G |
E2f7 |
E2F transcription factor 7 |
increases expression multiple interactions |
ISO |
lasiocarpine results in increased expression of E2F7 mRNA [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in increased expression of E2F7 mRNA |
CTD |
PMID:32234424 PMID:33884520 |
|
NCBI chr 7:46,150,533...46,192,739
Ensembl chr 7:46,151,293...46,192,734
|
|
G |
E2f8 |
E2F transcription factor 8 |
increases expression multiple interactions |
ISO |
lasiocarpine results in increased expression of E2F8 mRNA [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of E2F8 mRNA |
CTD |
PMID:32234424 PMID:33884520 |
|
NCBI chr 1:98,565,717...98,584,265
Ensembl chr 1:98,565,717...98,584,098
|
|
G |
Eda2r |
ectodysplasin A2 receptor |
increases expression |
EXP |
lasiocarpine results in increased expression of EDA2R mRNA |
CTD |
PMID:32419051 |
|
NCBI chr X:62,224,763...62,269,333
Ensembl chr X:62,228,229...62,269,268
|
|
G |
Enox1 |
ecto-NOX disulfide-thiol exchanger 1 |
decreases expression |
ISO |
lasiocarpine results in decreased expression of ENOX1 mRNA |
CTD |
PMID:32234424 PMID:35690182 |
|
NCBI chr15:52,517,833...53,079,752
Ensembl chr15:52,515,178...53,079,749
|
|
G |
Espl1 |
extra spindle pole bodies like 1, separase |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of ESPL1 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 7:133,424,027...133,450,984
Ensembl chr 7:133,424,130...133,450,984
|
|
G |
Exo1 |
exonuclease 1 |
increases expression |
ISO |
lasiocarpine results in increased expression of EXO1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr13:87,809,725...87,834,654
Ensembl chr13:87,809,810...87,834,654
|
|
G |
Fabp1 |
fatty acid binding protein 1 |
decreases expression |
ISO |
lasiocarpine results in decreased expression of FABP1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:103,191,015...103,194,791
Ensembl chr 4:103,191,006...103,194,788
|
|
G |
Fam151a |
family with sequence similarity 151, member A |
decreases expression |
ISO |
lasiocarpine results in decreased expression of FAM151A mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:121,514,804...121,527,555
Ensembl chr 5:121,514,804...121,527,555
|
|
G |
Fanca |
FA complementation group A |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of FANCA mRNA |
CTD |
PMID:33884520 |
|
NCBI chr19:51,304,126...51,362,586
Ensembl chr19:51,304,021...51,362,527
|
|
G |
Fancb |
FA complementation group B |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of FANCB mRNA |
CTD |
PMID:33884520 |
|
NCBI chr X:29,403,771...29,420,484
Ensembl chr X:29,403,771...29,420,192
|
|
G |
Fancd2 |
FA complementation group D2 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of FANCD2 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 4:146,679,014...146,743,422
Ensembl chr 4:146,679,179...146,743,412
|
|
G |
Fancg |
FA complementation group G |
increases expression |
ISO |
lasiocarpine results in increased expression of FANCG mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:57,230,287...57,240,067
Ensembl chr 5:57,231,685...57,240,029
|
|
G |
Fanci |
FA complementation group I |
increases expression |
ISO |
lasiocarpine results in increased expression of FANCI mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:133,327,264...133,383,661
Ensembl chr 1:133,327,297...133,383,640
|
|
G |
Fas |
Fas cell surface death receptor |
increases expression |
ISO |
lasiocarpine metabolite results in increased expression of FAS mRNA |
CTD |
PMID:30465738 |
|
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Fbxo5 |
F-box protein 5 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of FBXO5 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 1:42,196,068...42,202,437
Ensembl chr 1:42,196,068...42,202,437
|
|
G |
Fendrr |
FOXF1 adjacent non-coding developmental regulatory RNA |
increases expression |
ISO |
lasiocarpine results in increased expression of FENDRR mRNA |
CTD |
PMID:32234424 |
|
NCBI chr19:49,127,225...49,152,780
Ensembl chr19:49,121,214...49,153,240
|
|
G |
Fgf13 |
fibroblast growth factor 13 |
decreases expression |
ISO |
lasiocarpine results in decreased expression of FGF13 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr X:137,276,498...137,800,056
Ensembl chr X:137,276,511...137,800,391
|
|
G |
Fgf2 |
fibroblast growth factor 2 |
decreases expression |
ISO |
lasiocarpine metabolite results in decreased expression of FGF2 mRNA |
CTD |
PMID:30465738 |
|
NCBI chr 2:120,236,328...120,290,673
Ensembl chr 2:120,236,328...120,291,221
|
|
G |
Fhit |
fragile histidine triad diadenosine triphosphatase |
decreases expression |
ISO |
lasiocarpine results in decreased expression of FHIT mRNA |
CTD |
PMID:32234424 PMID:35690182 |
|
NCBI chr15:13,935,029...15,442,620
Ensembl chr15:13,934,995...15,442,340
|
|
G |
Firrm |
FIGNL1 interacting regulator of recombination and mitosis |
increases expression |
ISO |
lasiocarpine results in increased expression of FIRRM mRNA |
CTD |
PMID:32234424 |
|
NCBI chr13:76,301,914...76,345,842
Ensembl chr13:76,301,918...76,345,804
|
|
G |
Fn1 |
fibronectin 1 |
decreases expression |
ISO |
lasiocarpine metabolite results in decreased expression of FN1 mRNA |
CTD |
PMID:30465738 |
|
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
|
|
G |
Fosl1 |
FOS like 1, AP-1 transcription factor subunit |
increases expression |
ISO |
lasiocarpine results in increased expression of FOSL1 mRNA |
CTD |
PMID:32234424 PMID:35690182 |
|
NCBI chr 1:202,754,549...202,763,057
Ensembl chr 1:202,754,529...202,764,930
|
|
G |
G6pc1 |
glucose-6-phosphatase catalytic subunit 1 |
decreases expression |
ISO |
lasiocarpine results in decreased expression of G6PC1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr10:86,307,400...86,318,766
Ensembl chr10:86,257,668...86,333,804
|
|
G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in increased expression of GADD45A mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115
|
|
G |
Gdf15 |
growth differentiation factor 15 |
increases expression |
ISO |
lasiocarpine results in increased expression of GDF15 mRNA |
CTD |
PMID:32234424 PMID:35690182 |
|
NCBI chr16:18,804,457...18,808,043
Ensembl chr16:18,805,239...18,808,055
|
|
G |
Gnmt |
glycine N-methyltransferase |
decreases expression |
ISO |
lasiocarpine results in decreased expression of GNMT mRNA |
CTD |
PMID:32234424 PMID:35690182 |
|
NCBI chr 9:14,254,675...14,258,028
Ensembl chr 9:14,254,675...14,258,434
|
|
G |
Gpc6 |
glypican 6 |
decreases expression |
ISO |
lasiocarpine results in decreased expression of GPC6 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr15:94,030,218...95,027,883
Ensembl chr15:94,029,884...95,024,006
|
|
G |
Gpr161 |
G protein-coupled receptor 161 |
increases expression |
ISO |
lasiocarpine results in increased expression of GPR161 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr13:77,578,257...77,623,661
Ensembl chr13:77,577,739...77,619,613
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
affects activity |
EXP |
lasiocarpine affects the activity of GPT protein |
CTD |
PMID:32419051 |
|
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Grap2 |
GRB2-related adaptor protein 2 |
increases expression |
ISO |
lasiocarpine results in increased expression of GRAP2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 7:112,117,142...112,190,880
Ensembl chr 7:112,117,142...112,190,877
|
|
G |
Gucy2e |
guanylate cyclase 2E |
decreases expression |
ISO |
lasiocarpine results in decreased expression of GUCY2D mRNA |
CTD |
PMID:32234424 |
|
NCBI chr10:53,954,918...53,975,576
Ensembl chr10:53,959,010...53,974,067
|
|
G |
Gzma |
granzyme A |
decreases expression |
EXP |
lasiocarpine results in decreased expression of GZMA mRNA |
CTD |
PMID:32419051 |
|
NCBI chr 2:44,740,569...44,752,502
Ensembl chr 2:44,740,569...44,752,493
|
|
G |
H2ax |
H2A.X variant histone |
increases phosphorylation multiple interactions increases expression |
EXP ISO |
lasiocarpine results in increased phosphorylation of H2AX protein [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in increased phosphorylation of H2AX protein lasiocarpine results in increased expression of H2AX protein |
CTD |
PMID:31103741 PMID:31154085 PMID:31289892 |
|
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239 Ensembl chr 4:44,671,786...44,673,239
|
|
G |
Hells |
helicase, lymphoid specific |
increases expression |
ISO |
lasiocarpine results in increased expression of HELLS mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:236,701,704...236,748,239
Ensembl chr 1:236,701,758...236,746,844
|
|
G |
Hhat |
hedgehog acyltransferase |
decreases expression |
ISO |
lasiocarpine results in decreased expression of HHAT mRNA |
CTD |
PMID:32234424 |
|
NCBI chr13:104,024,507...104,283,580
Ensembl chr13:104,010,916...104,282,893
|
|
G |
Hjv |
hemojuvelin BMP co-receptor |
decreases expression |
ISO |
lasiocarpine results in decreased expression of HJV mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:184,065,944...184,069,851
Ensembl chr 2:184,065,970...184,069,850
|
|
G |
Hltf |
helicase-like transcription factor |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of HLTF mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 2:102,549,724...102,609,492
Ensembl chr 2:102,549,724...102,609,327
|
|
G |
Hmcn1 |
hemicentin 1 |
decreases expression |
ISO |
lasiocarpine results in decreased expression of HMCN1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr13:62,615,461...63,084,524
Ensembl chr13:62,615,461...63,084,524
|
|
G |
Hmgn5 |
high mobility group nucleosome binding domain 5 |
increases expression |
EXP |
lasiocarpine results in increased expression of HMGN5 mRNA |
CTD |
PMID:34185104 |
|
NCBI chr X:74,085,871...74,094,488
Ensembl chr X:74,085,875...74,094,441 Ensembl chr 1:74,085,875...74,094,441
|
|
G |
Hpgd |
15-hydroxyprostaglandin dehydrogenase |
decreases expression |
EXP |
lasiocarpine results in decreased expression of HPGD mRNA |
CTD |
PMID:32419051 |
|
NCBI chr16:33,986,265...34,024,228
Ensembl chr16:33,986,266...34,024,228
|
|
G |
Hs6st3 |
heparan sulfate 6-O-sulfotransferase 3 |
decreases expression |
ISO |
lasiocarpine results in decreased expression of HS6ST3 mRNA |
CTD |
PMID:32234424 PMID:35690182 |
|
NCBI chr15:96,281,502...97,000,804
Ensembl chr15:96,281,646...97,000,462
|
|
G |
Hsd17b13 |
hydroxysteroid (17-beta) dehydrogenase 13 |
increases expression |
EXP |
lasiocarpine results in increased expression of HSD17B13 mRNA |
CTD |
PMID:32419051 |
|
NCBI chr14:5,751,697...5,766,809
Ensembl chr14:5,752,132...5,768,166
|
|
G |
Igsf23 |
immunoglobulin superfamily, member 23 |
decreases expression |
ISO |
lasiocarpine results in decreased expression of IGSF23 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:79,591,059...79,606,323
Ensembl chr 1:79,592,088...79,610,438
|
|
G |
Il11 |
interleukin 11 |
increases expression |
ISO |
lasiocarpine metabolite results in increased expression of IL11 mRNA |
CTD |
PMID:30465738 |
|
NCBI chr 1:69,069,829...69,076,129
Ensembl chr 1:69,068,137...69,076,129
|
|
G |
Il17rd |
interleukin 17 receptor D |
increases expression |
EXP |
lasiocarpine results in increased expression of IL17RD mRNA |
CTD |
PMID:32419051 |
|
NCBI chr16:2,228,438...2,295,122
Ensembl chr16:2,228,287...2,292,556
|
|
G |
Il1b |
interleukin 1 beta |
increases expression |
ISO |
lasiocarpine metabolite results in increased expression of IL1B mRNA |
CTD |
PMID:30465738 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Immp2l |
inner mitochondrial membrane peptidase subunit 2 |
decreases expression |
ISO |
lasiocarpine results in decreased expression of IMMP2L mRNA |
CTD |
PMID:32234424 PMID:35690182 |
|
NCBI chr 6:58,070,035...58,970,165
Ensembl chr 6:58,070,283...58,969,840
|
|
G |
Inpp5d |
inositol polyphosphate-5-phosphatase D |
increases expression |
ISO |
lasiocarpine results in increased expression of INPP5D mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 9:88,287,680...88,392,748
Ensembl chr 9:88,287,677...88,392,746
|
|
G |
Itga8 |
integrin subunit alpha 8 |
decreases expression |
ISO |
lasiocarpine results in decreased expression of ITGA8 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr17:75,304,004...75,501,510
Ensembl chr17:75,304,008...75,501,510
|
|
G |
Jam3 |
junctional adhesion molecule 3 |
increases expression |
EXP |
lasiocarpine results in increased expression of JAM3 mRNA |
CTD |
PMID:32419051 |
|
NCBI chr 8:25,508,461...25,569,306
Ensembl chr 8:25,507,057...25,569,355
|
|
G |
Kcnma1 |
potassium calcium-activated channel subfamily M alpha 1 |
decreases expression |
ISO |
lasiocarpine results in decreased expression of KCNMA1 mRNA |
CTD |
PMID:32234424 PMID:35690182 |
|
NCBI chr15:302,480...1,007,675
Ensembl chr15:302,214...1,001,198
|
|
G |
Kiaa0319 |
KIAA0319 homolog |
increases expression |
ISO |
lasiocarpine results in increased expression of KIAA0319 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr17:40,162,512...40,226,666
Ensembl chr17:40,165,084...40,225,653
|
|
G |
Kif11 |
kinesin family member 11 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of KIF11 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 1:235,124,371...235,176,760
Ensembl chr 1:235,124,316...235,176,766
|
|
G |
Kif23 |
kinesin family member 23 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of lasiocarpine] which affects the expression of KIF23 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 8:62,397,908...62,425,162
Ensembl chr 8:62,397,948...62,425,072
|
|
G |
Kmo |
kynurenine 3-monooxygenase |
decreases expression |
ISO |
lasiocarpine results in decreased expression of KMO mRNA |
CTD |
PMID:32234424 |
|
NCBI chr13:87,557,080...87,589,334
Ensembl chr13:87,557,286...87,588,881
|
|
G |
Lamp3 |
lysosomal-associated membrane protein 3 |
increases expression |
ISO |
lasiocarpine results in increased expression of LAMP3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr11:81,153,491...81,224,643
Ensembl chr11:81,193,649...81,221,784
|
|
G |
Lif |
LIF, interleukin 6 family cytokine |
increases expression |
ISO |
lasiocarpine results in increased expression of LIF mRNA |
CTD |
PMID:32234424 PMID:35690182 |
|
NCBI chr14:79,131,049...79,140,486
Ensembl chr14:79,134,574...79,140,482
|
|
G |
Lingo4 |
leucine rich repeat and Ig domain containing 4 |
decreases expression |
ISO |
lasiocarpine results in decreased expression of LINGO4 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:182,035,522...182,040,787
Ensembl chr 2:182,014,326...182,040,787
|
|
G |
Lrmda |
leucine rich melanocyte differentiation associated |
decreases expression |
ISO |
lasiocarpine results in decreased expression of LRMDA mRNA |
CTD |
PMID:32234424 PMID:35690182 |
|
NCBI chr15:1,223,098...2,284,764
Ensembl chr15:1,225,710...2,284,749
|
|
G |
Lrrc39 |
leucine rich repeat containing 39 |
decreases expression |
ISO |
lasiocarpine results in decreased expression of LRRC39 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:204,516,122...204,535,463
Ensembl chr 2:204,516,123...204,535,463
|
|
G |
Lzts1 |
leucine zipper tumor suppressor 1 |
increases expression |
ISO |
lasiocarpine results in increased expression of LZTS1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr16:20,542,756...20,598,204
Ensembl chr16:20,542,809...20,598,203
|
|
G |
Mab21l4 |
mab-21 like 4 |
decreases expression |
ISO |
lasiocarpine results in decreased expression of MAB21L4 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 9:93,690,455...93,701,267
Ensembl chr 9:93,690,999...93,700,506
|
|
G |
Macrod2 |
mono-ADP ribosylhydrolase 2 |
decreases expression |
ISO |
lasiocarpine results in decreased expression of MACROD2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 3:127,720,066...129,737,511
Ensembl chr 3:127,720,181...129,734,492
|
|
G |
Mbl2 |
mannose binding lectin 2 |
decreases expression |
ISO |
lasiocarpine results in decreased expression of MBL2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:228,016,439...228,024,736
|
|
G |
Mcm10 |
minichromosome maintenance 10 replication initiation factor |
increases expression |
ISO |
lasiocarpine results in increased expression of MCM10 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr17:73,263,788...73,288,346
Ensembl chr17:73,266,095...73,287,364
|
|
G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
increases expression |
EXP |
lasiocarpine results in increased expression of MGMT mRNA |
CTD |
PMID:32419051 |
|
NCBI chr 1:191,710,980...191,937,760
Ensembl chr 1:191,710,930...191,937,756
|
|
G |
Mlh1 |
mutL homolog 1 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of MLH1 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 8:111,196,468...111,233,721
Ensembl chr 8:111,196,468...111,233,617
|
|
G |
Mnd1 |
meiotic nuclear divisions 1 |
increases expression |
ISO |
lasiocarpine results in increased expression of MND1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:169,433,523...169,496,081
Ensembl chr 2:169,433,540...169,496,096
|
|
G |
Mpp2 |
MAGUK p55 scaffold protein 2 |
increases expression |
ISO |
lasiocarpine results in increased expression of MPP2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr10:87,011,434...87,043,883
Ensembl chr10:87,011,434...87,043,896
|
|
G |
Mre11 |
MRE11 homolog, double strand break repair nuclease |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of MRE11 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 8:11,618,876...11,680,451
Ensembl chr 8:11,632,354...11,678,279
|
|
G |
Msh2 |
mutS homolog 2 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of MSH2 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 6:6,813,793...6,872,960
Ensembl chr 6:6,813,795...6,872,938
|
|
G |
Msh6 |
mutS homolog 6 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of MSH6 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 6:6,562,631...6,579,995
Ensembl chr 6:6,562,632...6,579,956
|
|
G |
Muc13 |
mucin 13, cell surface associated |
increases expression |
ISO |
lasiocarpine results in increased expression of MUC13 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr11:66,957,208...66,980,264
Ensembl chr11:66,960,595...66,984,727
|
|
G |
Mybl1 |
MYB proto-oncogene like 1 |
increases expression |
EXP |
lasiocarpine results in increased expression of MYBL1 mRNA |
CTD |
PMID:32419051 |
|
NCBI chr 5:9,582,905...9,618,179
Ensembl chr 5:9,582,934...9,618,183
|
|
G |
Mybl2 |
MYB proto-oncogene like 2 |
increases expression |
ISO EXP |
lasiocarpine results in increased expression of MYBL2 mRNA |
CTD |
PMID:32234424 PMID:32419051 |
|
NCBI chr 3:151,705,254...151,733,714
Ensembl chr 3:151,705,288...151,733,708
|
|
G |
Myo10 |
myosin X |
increases expression |
ISO |
lasiocarpine results in increased expression of MYO10 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:76,100,989...76,305,619
Ensembl chr 2:76,100,987...76,303,030
|
|
G |
Naaladl2 |
N-acetylated alpha-linked acidic dipeptidase-like 2 |
decreases expression |
ISO |
lasiocarpine results in decreased expression of NAALADL2 mRNA |
CTD |
PMID:32234424 PMID:35690182 |
|
NCBI chr 2:106,639,146...107,992,218
Ensembl chr 2:106,645,608...107,991,689
|
|
G |
Ncf2 |
neutrophil cytosolic factor 2 |
increases expression |
ISO |
lasiocarpine results in increased expression of NCF2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr13:64,955,622...64,986,144
Ensembl chr13:64,955,503...64,986,277
|
|
G |
Nectin4 |
nectin cell adhesion molecule 4 |
increases expression |
ISO |
lasiocarpine results in increased expression of NECTIN4 mRNA |
CTD |
PMID:32234424 PMID:35690182 |
|
NCBI chr13:83,802,589...83,821,711
Ensembl chr13:83,803,184...83,821,709
|
|
G |
Ninl |
ninein-like |
decreases expression |
ISO |
lasiocarpine results in decreased expression of NINL mRNA |
CTD |
PMID:32234424 PMID:35690182 |
|
NCBI chr 3:139,748,353...139,814,683
Ensembl chr 3:139,748,355...139,814,622
|
|
G |
Npas3 |
neuronal PAS domain protein 3 |
decreases expression |
ISO |
lasiocarpine results in decreased expression of NPAS3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 6:70,702,773...71,527,928
Ensembl chr 6:70,703,170...71,524,884
|
|
G |
Npr1 |
natriuretic peptide receptor 1 |
decreases expression |
ISO |
lasiocarpine metabolite results in decreased expression of NPR1 mRNA |
CTD |
PMID:30465738 |
|
NCBI chr 2:175,934,181...175,950,118
Ensembl chr 2:175,934,181...175,949,505
|
|
G |
Nr0b2 |
nuclear receptor subfamily 0, group B, member 2 |
decreases expression |
ISO |
lasiocarpine results in decreased expression of NR0B2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:145,779,294...145,782,609
Ensembl chr 5:145,779,294...145,782,609
|
|
G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
decreases expression |
ISO |
lasiocarpine results in decreased expression of NR1I3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
|
|
G |
Nrcam |
neuronal cell adhesion molecule |
increases expression |
EXP |
lasiocarpine results in increased expression of NRCAM mRNA |
CTD |
PMID:32419051 |
|
NCBI chr 6:61,402,813...61,698,536
Ensembl chr 6:61,329,863...61,702,992
|
|
G |
Nrgn |
neurogranin |
increases expression |
ISO |
lasiocarpine results in increased expression of NRGN mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 8:37,255,462...37,263,659
Ensembl chr 8:37,256,930...37,257,516
|
|
G |
Nts |
neurotensin |
decreases expression |
ISO |
lasiocarpine results in decreased expression of NTS mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 7:37,564,944...37,574,350
Ensembl chr 7:37,564,533...37,574,423
|
|
G |
Nupr1 |
nuclear protein 1, transcriptional regulator |
increases expression |
EXP |
lasiocarpine results in increased expression of NUPR1 mRNA |
CTD |
PMID:32419051 |
|
NCBI chr 1:181,213,292...181,215,327
Ensembl chr 1:181,213,368...181,215,281
|
|
G |
Orc1 |
origin recognition complex, subunit 1 |
increases expression |
ISO |
lasiocarpine results in increased expression of ORC1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:123,324,273...123,348,375
Ensembl chr 5:123,324,315...123,348,375
|
|
G |
Pak5 |
p21 (RAC1) activated kinase 5 |
decreases expression |
ISO |
lasiocarpine results in decreased expression of PAK5 mRNA |
CTD |
PMID:32234424 PMID:35690182 |
|
NCBI chr 3:123,395,678...123,703,967
Ensembl chr 3:123,396,497...123,703,930
|
|
G |
Pecam1 |
platelet and endothelial cell adhesion molecule 1 |
decreases expression |
ISO |
lasiocarpine metabolite results in decreased expression of PECAM1 mRNA |
CTD |
PMID:30465738 |
|
NCBI chr10:91,590,521...91,652,279
Ensembl chr10:91,590,521...91,652,116
|
|
G |
Pfkfb1 |
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1 |
decreases expression |
ISO |
lasiocarpine results in decreased expression of PFKFB1 mRNA |
CTD |
PMID:32234424 PMID:35690182 |
|
NCBI chr X:19,508,522...19,562,165
Ensembl chr X:19,508,546...19,562,182
|
|
G |
Pglyrp2 |
peptidoglycan recognition protein 2 |
decreases expression |
ISO |
lasiocarpine results in decreased expression of PGLYRP2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 7:11,418,674...11,432,162
Ensembl chr 7:11,418,880...11,427,773
|
|
G |
Phf10 |
PHD finger protein 10 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of PHF10 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 1:55,952,249...55,968,994
Ensembl chr 1:55,952,253...55,969,038
|
|
G |
Pklr |
pyruvate kinase L/R |
decreases expression |
ISO |
lasiocarpine results in decreased expression of PKLR mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:174,543,008...174,551,863
Ensembl chr 2:174,543,039...174,551,870
|
|
G |
Plg |
plasminogen |
decreases expression |
ISO |
lasiocarpine results in decreased expression of PLG mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:48,325,186...48,367,643
Ensembl chr 1:48,325,185...48,367,786
|
|
G |
Plk1 |
polo-like kinase 1 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of PLK1 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 1:176,716,420...176,726,400
Ensembl chr 1:176,716,420...176,726,400
|
|
G |
Plk2 |
polo-like kinase 2 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in increased expression of PLK2 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 2:41,969,176...41,974,945
Ensembl chr 2:41,969,176...41,974,947
|
|
G |
Plk3 |
polo-like kinase 3 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in increased expression of PLK3 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 5:130,607,142...130,612,317
Ensembl chr 5:130,607,142...130,612,317
|
|
G |
Plk4 |
polo-like kinase 4 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of PLK4 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 2:123,802,527...123,820,942
Ensembl chr 2:123,802,512...123,820,942
|
|
G |
Pltp |
phospholipid transfer protein |
decreases expression |
EXP |
lasiocarpine results in decreased expression of PLTP mRNA |
CTD |
PMID:32419051 |
|
NCBI chr 3:153,574,825...153,592,647
Ensembl chr 3:153,574,825...153,592,647
|
|
G |
Pole2 |
DNA polymerase epsilon 2, accessory subunit |
increases expression |
ISO |
lasiocarpine results in increased expression of POLE2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 6:87,674,702...87,712,723
Ensembl chr 6:87,674,702...87,699,305
|
|
G |
Polq |
DNA polymerase theta |
increases expression |
ISO |
lasiocarpine results in increased expression of POLQ mRNA |
CTD |
PMID:32234424 |
|
NCBI chr11:63,673,796...63,775,905
Ensembl chr11:63,673,816...63,775,878
|
|
G |
Pou2f1 |
POU class 2 homeobox 1 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of POU2F1 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr13:78,120,617...78,263,306
Ensembl chr13:78,130,685...78,263,363
|
|
G |
Ppp2cb |
protein phosphatase 2 catalytic subunit beta |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in increased expression of PPP2CB mRNA |
CTD |
PMID:33884520 |
|
NCBI chr16:58,558,119...58,579,325
Ensembl chr16:58,558,122...58,579,576
|
|
G |
Ppp2r2b |
protein phosphatase 2, regulatory subunit B, beta |
decreases expression |
ISO |
lasiocarpine results in decreased expression of PPP2R2B mRNA |
CTD |
PMID:32234424 |
|
NCBI chr18:34,653,716...35,080,889
Ensembl chr18:34,653,721...35,081,025
|
|
G |
Ppp2r5d |
protein phosphatase 2, regulatory subunit B', delta |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of PPP2R5D mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 9:14,270,364...14,300,396
Ensembl chr 9:14,268,745...14,300,400
|
|
G |
Prc1 |
protein regulator of cytokinesis 1 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of PRC1 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 1:134,250,086...134,271,765
Ensembl chr 1:134,250,081...134,271,765
|
|
G |
Prkn |
parkin RBR E3 ubiquitin protein ligase |
decreases expression |
ISO |
lasiocarpine results in decreased expression of PARK2 mRNA; lasiocarpine results in decreased expression of PRKN mRNA |
CTD |
PMID:32234424 PMID:35690182 |
|
NCBI chr 1:48,688,651...49,882,520
Ensembl chr 1:48,690,556...49,882,555
|
|
G |
Psmc3ip |
PSMC3 interacting protein |
increases expression |
ISO |
lasiocarpine results in increased expression of PSMC3IP mRNA |
CTD |
PMID:32234424 |
|
NCBI chr10:86,024,281...86,027,928
Ensembl chr10:86,023,950...86,027,423
|
|
G |
Ptgis |
prostaglandin I2 synthase |
decreases expression decreases expression |
ISO |
lasiocarpine metabolite results in decreased expression of PTGIS mRNA; lasiocarpine metabolite results in decreased expression of PTGIS protein [Lasiocarpine cotreated with liver homogenate supernatant] decreases expression of PTGIS mRNA in vascular endothelial cells |
CTD RGD |
PMID:30465738 PMID:30465738 |
RGD:401959398 |
NCBI chr 3:155,928,564...155,964,228
Ensembl chr 3:155,916,412...155,965,451
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
increases expression |
ISO |
lasiocarpine metabolite results in increased expression of PTGS2 mRNA; lasiocarpine metabolite results in increased expression of PTGS2 protein |
CTD |
PMID:30465738 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Pttg1 |
PTTG1 regulator of sister chromatid separation, securin |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of PTTG1 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr10:27,893,466...27,904,965
Ensembl chr10:27,893,689...27,904,837
|
|
G |
Rad1 |
RAD1 checkpoint DNA exonuclease |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of RAD1 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 2:59,461,597...59,469,707
Ensembl chr 2:59,461,607...59,469,689
|
|
G |
Rad17 |
RAD17 checkpoint clamp loader component |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of RAD17 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 2:31,764,260...31,794,542
Ensembl chr 2:31,764,261...31,794,072
|
|
G |
Rad21 |
RAD21 cohesin complex component |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of RAD21 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 7:83,287,867...83,314,810
Ensembl chr 7:83,287,870...83,314,817
|
|
G |
Rad51b |
RAD51 paralog B |
decreases expression |
ISO |
lasiocarpine results in decreased expression of RAD51B mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 6:98,096,525...98,640,988
Ensembl chr 6:98,098,868...98,640,979
|
|
G |
Rbbp8 |
RB binding protein 8, endonuclease |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of RBBP8 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr18:2,922,985...2,988,851
Ensembl chr18:2,921,286...2,988,846
|
|
G |
Rbl1 |
RB transcriptional corepressor like 1 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of RBL1 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 3:145,806,160...145,869,434
Ensembl chr 3:145,807,095...145,869,330
|
|
G |
Rdh16 |
retinol dehydrogenase 16 |
decreases expression |
ISO |
lasiocarpine results in decreased expression of RDH16 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 7:63,616,711...63,625,053
Ensembl chr 7:63,597,536...63,624,124
|
|
G |
Rfc1 |
replication factor C subunit 1 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of RFC1 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr14:42,966,279...43,041,372
Ensembl chr14:42,966,324...43,041,370
|
|
G |
Rfc2 |
replication factor C subunit 2 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of RFC2 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr12:22,120,449...22,133,576
Ensembl chr12:22,120,010...22,133,557
|
|
G |
Rfc3 |
replication factor C subunit 3 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of RFC3 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr12:1,000,987...1,011,778
Ensembl chr12:1,000,994...1,011,778
|
|
G |
Rfc4 |
replication factor C subunit 4 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of RFC4 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr11:77,749,642...77,764,123
Ensembl chr11:77,749,638...77,764,122
|
|
G |
Rfc5 |
replication factor C subunit 5 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of RFC5 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr12:39,207,484...39,217,041
Ensembl chr12:39,207,484...39,217,312
|
|
G |
Rgs16 |
regulator of G-protein signaling 16 |
increases expression |
ISO |
lasiocarpine results in increased expression of RGS16 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr13:65,887,668...65,892,862
Ensembl chr13:65,887,530...65,892,857
|
|
G |
Rhbdl3 |
rhomboid like 3 |
increases expression |
ISO |
lasiocarpine results in increased expression of RHBDL3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr10:65,299,250...65,354,099
Ensembl chr10:65,299,194...65,354,099
|
|
G |
Rhbg |
Rh family B glycoprotein |
decreases expression |
ISO |
lasiocarpine results in decreased expression of RHBG mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:173,704,852...173,717,380
Ensembl chr 2:173,704,562...173,717,321
|
|
G |
Rpa1 |
replication protein A1 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of RPA1 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr10:60,148,869...60,199,970
Ensembl chr10:60,148,793...60,199,949
|
|
G |
Rrad |
RRAD, Ras related glycolysis inhibitor and calcium channel regulator |
increases expression |
ISO |
lasiocarpine results in increased expression of RRAD mRNA |
CTD |
PMID:32234424 PMID:35690182 |
|
NCBI chr19:354,184...357,424
Ensembl chr19:354,198...357,417
|
|
G |
S100a2 |
S100 calcium binding protein A2 |
increases expression |
ISO |
lasiocarpine results in increased expression of S100A2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:176,077,081...176,078,325
|
|
G |
Sbk1 |
SH3 domain binding kinase 1 |
increases expression |
ISO |
lasiocarpine results in increased expression of SBK1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:180,807,092...180,851,910
Ensembl chr 1:180,807,099...180,851,885
|
|
G |
Sdk1 |
sidekick cell adhesion molecule 1 |
decreases expression |
ISO |
lasiocarpine results in decreased expression of SDK1 mRNA |
CTD |
PMID:32234424 PMID:35690182 |
|
NCBI chr12:12,378,074...13,363,934
Ensembl chr12:12,380,524...13,363,976
|
|
G |
Serpinb2 |
serpin family B member 2 |
increases expression |
ISO |
lasiocarpine results in increased expression of SERPINB2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr13:23,537,312...23,551,823
Ensembl chr13:23,541,400...23,550,408
|
|
G |
Sfn |
stratifin |
increases expression |
ISO |
lasiocarpine results in increased expression of SFN mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:145,826,722...145,827,994
Ensembl chr 5:145,826,201...145,831,314
|
|
G |
Sh3rf3 |
SH3 domain containing ring finger 3 |
decreases expression |
ISO |
lasiocarpine results in decreased expression of SH3RF3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr20:26,765,278...27,099,261
Ensembl chr20:26,765,015...27,099,257
|
|
G |
Slc19a1 |
solute carrier family 19 member 1 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of SLC19A1 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr20:11,584,410...11,602,429
Ensembl chr20:11,584,411...11,601,972
|
|
G |
Slc27a5 |
solute carrier family 27 member 5 |
decreases expression |
ISO |
lasiocarpine results in decreased expression of SLC27A5 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:73,616,556...73,627,149
Ensembl chr 1:73,616,564...73,627,172
|
|
G |
Smarcc1 |
SWI/SNF related BAF chromatin remodeling complex subunit C1 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of SMARCC1 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 8:110,111,097...110,214,734
Ensembl chr 8:110,111,122...110,214,720
|
|
G |
Smc1a |
structural maintenance of chromosomes 1A |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of SMC1A mRNA |
CTD |
PMID:33884520 |
|
NCBI chr X:21,103,323...21,148,053
Ensembl chr X:21,103,282...21,148,056
|
|
G |
Smc3 |
structural maintenance of chromosomes 3 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of SMC3 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 1:252,601,422...252,644,522
Ensembl chr 1:252,601,753...252,644,522
|
|
G |
Smpd3 |
sphingomyelin phosphodiesterase 3 |
decreases expression |
ISO |
lasiocarpine results in decreased expression of SMPD3 mRNA |
CTD |
PMID:32234424 PMID:35690182 |
|
NCBI chr19:34,162,337...34,245,786
Ensembl chr19:34,162,341...34,245,749
|
|
G |
Sparcl1 |
SPARC like 1 |
decreases expression |
ISO |
lasiocarpine results in decreased expression of SPARCL1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr14:5,632,816...5,663,866
Ensembl chr14:5,632,569...5,663,865
|
|
G |
Spock3 |
SPARC/osteonectin, cwcv and kazal like domains proteoglycan 3 |
decreases expression |
ISO |
lasiocarpine results in decreased expression of SPOCK3 mRNA |
CTD |
PMID:32234424 PMID:35690182 |
|
NCBI chr16:26,382,895...26,815,943
Ensembl chr16:26,383,383...26,815,205
|
|
G |
Src |
SRC proto-oncogene, non-receptor tyrosine kinase |
increases expression |
ISO |
lasiocarpine results in increased expression of SRC mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 3:146,091,969...146,139,492
Ensembl chr 3:146,091,841...146,139,476
|
|
G |
Stac3 |
SH3 and cysteine rich domain 3 |
decreases expression |
EXP |
lasiocarpine results in decreased expression of STAC3 mRNA |
CTD |
PMID:32419051 |
|
NCBI chr 7:63,343,078...63,350,590
Ensembl chr 7:63,343,186...63,350,589
|
|
G |
Stag2 |
STAG2 cohesin complex component |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of STAG2 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr X:120,974,687...121,105,677
Ensembl chr X:120,974,857...121,105,677
|
|
G |
Stat1 |
signal transducer and activator of transcription 1 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in increased expression of STAT1 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 9:49,419,561...49,459,969
Ensembl chr 9:49,419,340...49,588,540
|
|
G |
Stc1 |
stanniocalcin 1 |
increases expression |
EXP |
lasiocarpine results in increased expression of STC1 mRNA |
CTD |
PMID:34185104 |
|
NCBI chr15:44,299,591...44,311,695
Ensembl chr15:44,299,621...44,310,264
|
|
G |
Stk31 |
serine threonine kinase 31 |
decreases expression |
ISO |
lasiocarpine results in decreased expression of STK31 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:78,370,691...78,467,599
Ensembl chr 4:78,370,649...78,466,240
|
|
G |
Sucnr1 |
succinate receptor 1 |
decreases expression |
ISO |
lasiocarpine results in decreased expression of SUCNR1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:144,219,066...144,230,568
Ensembl chr 2:144,219,122...144,230,034
|
|
G |
Sugct |
succinylCoA:glutarate-CoA transferase |
decreases expression |
ISO |
lasiocarpine results in decreased expression of SUGCT mRNA |
CTD |
PMID:32234424 PMID:35690182 |
|
NCBI chr17:47,376,392...48,234,362
Ensembl chr17:47,376,521...48,234,376
|
|
G |
Tcf19 |
transcription factor 19 |
increases expression |
ISO |
lasiocarpine results in increased expression of TCF19 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr20:3,218,756...3,222,861
Ensembl chr20:3,218,693...3,223,271
|
|
G |
Tek |
TEK receptor tyrosine kinase |
decreases expression |
ISO |
lasiocarpine metabolite results in decreased expression of TEK mRNA |
CTD |
PMID:30465738 |
|
NCBI chr 5:109,607,077...109,733,805
Ensembl chr 5:109,607,077...109,733,804
|
|
G |
Tex15 |
testis expressed 15, meiosis and synapsis associated |
increases expression |
ISO |
lasiocarpine results in increased expression of TEX15 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr16:58,598,991...58,659,005
Ensembl chr16:58,598,989...58,658,467
|
|
G |
Tfpi |
tissue factor pathway inhibitor |
decreases expression |
ISO |
lasiocarpine metabolite results in decreased expression of TFPI mRNA |
CTD |
PMID:30465738 |
|
NCBI chr 3:69,533,156...69,582,547
Ensembl chr 3:69,533,156...69,576,880
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
decreases expression |
ISO |
lasiocarpine metabolite results in decreased expression of TGFB1 mRNA |
CTD |
PMID:30465738 |
|
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Thrsp |
thyroid hormone responsive |
decreases expression |
ISO |
lasiocarpine results in decreased expression of THRSP mRNA |
CTD |
PMID:32234424 PMID:35690182 |
|
NCBI chr 1:151,723,415...151,727,740
Ensembl chr 1:151,723,086...151,728,075
|
|
G |
Tlk1 |
tousled-like kinase 1 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of TLK1 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 3:55,520,559...55,627,580
Ensembl chr 3:55,503,358...55,691,968
|
|
G |
Tlr8 |
toll-like receptor 8 |
increases expression |
EXP |
lasiocarpine results in increased expression of TLR8 mRNA |
CTD |
PMID:34185104 |
|
NCBI chr X:27,091,780...27,116,092
Ensembl chr X:27,091,778...27,116,549
|
|
G |
Tmem266 |
transmembrane protein 266 |
decreases expression |
ISO |
lasiocarpine results in decreased expression of TMEM266 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 8:55,707,122...55,820,692
Ensembl chr 8:55,707,122...55,820,692
|
|
G |
Tmsb15b2 |
thymosin beta 15B2 |
increases expression |
ISO |
lasiocarpine results in increased expression of TMSB15A mRNA |
CTD |
PMID:32234424 |
|
NCBI chr X:100,298,705...100,300,820
Ensembl chr X:100,298,514...100,300,886
|
|
G |
Tnfsf10 |
TNF superfamily member 10 |
decreases expression |
ISO |
lasiocarpine metabolite results in decreased expression of TNFSF10 mRNA |
CTD |
PMID:30465738 |
|
NCBI chr 2:110,199,835...110,227,239
Ensembl chr 2:110,207,916...110,225,135
|
|
G |
Top2a |
DNA topoisomerase II alpha |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of TOP2A mRNA |
CTD |
PMID:33884520 |
|
NCBI chr10:83,945,731...83,976,874
Ensembl chr10:83,945,735...83,976,874
|
|
G |
Topbp1 |
DNA topoisomerase II binding protein 1 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of TOPBP1 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 8:103,887,805...103,931,662
Ensembl chr 8:103,887,865...103,931,674
|
|
G |
Tp73 |
tumor protein p73 |
increases expression |
ISO |
lasiocarpine results in increased expression of TP73 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:164,621,377...164,703,958
Ensembl chr 5:164,621,377...164,681,128
|
|
G |
Trip13 |
thyroid hormone receptor interactor 13 |
increases expression |
ISO |
lasiocarpine results in increased expression of TRIP13 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:29,357,093...29,402,078
Ensembl chr 1:29,357,130...29,402,074
|
|
G |
Trpa1 |
transient receptor potential cation channel, subfamily A, member 1 |
increases expression |
ISO |
lasiocarpine results in increased expression of TRPA1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:4,379,862...4,434,133
Ensembl chr 5:4,379,999...4,433,570
|
|
G |
Tspan15 |
tetraspanin 15 |
increases expression |
ISO |
lasiocarpine results in increased expression of TSPAN15 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr20:30,130,528...30,174,912
Ensembl chr20:30,130,530...30,174,930
|
|
G |
Tymp |
thymidine phosphorylase |
increases expression |
ISO |
lasiocarpine metabolite results in increased expression of TYMP mRNA |
CTD |
PMID:30465738 |
|
NCBI chr 7:120,438,768...120,444,088
Ensembl chr 7:120,438,770...120,443,874 Ensembl chr 7:120,438,770...120,443,874
|
|
G |
Tyrp1 |
tyrosinase-related protein 1 |
decreases expression |
ISO |
lasiocarpine results in decreased expression of TYRP1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:95,280,982...95,299,516
Ensembl chr 5:95,280,982...95,299,516
|
|
G |
Ugt2b1 |
UDP glucuronosyltransferase 2 family, polypeptide B1 |
increases expression |
EXP |
lasiocarpine results in increased expression of UGT2B17 mRNA |
CTD |
PMID:32419051 |
|
NCBI chr14:21,024,035...21,035,784
Ensembl chr14:21,024,006...21,035,986
|
|
G |
Uhrf1 |
ubiquitin-like with PHD and ring finger domains 1 |
increases expression |
ISO |
lasiocarpine results in increased expression of UHRF1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 9:1,133,117...1,154,639
Ensembl chr 9:1,134,909...1,154,631
|
|
G |
Ust5r |
integral membrane transport protein UST5r |
decreases expression |
ISO |
lasiocarpine results in decreased expression of SLC22A25 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:205,210,558...205,286,868
Ensembl chr 1:205,211,034...205,286,718
|
|
G |
Vwf |
von Willebrand factor |
decreases expression |
ISO |
lasiocarpine metabolite results in decreased expression of VWF mRNA |
CTD |
PMID:30465738 |
|
NCBI chr 4:158,360,152...158,491,539
Ensembl chr 4:158,360,152...158,491,539
|
|
G |
Wee1 |
WEE1 G2 checkpoint kinase |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of WEE1 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 1:164,173,681...164,197,688
Ensembl chr 1:164,174,779...164,197,688
|
|
G |
Wnt7b |
Wnt family member 7B |
increases expression |
ISO |
lasiocarpine results in increased expression of WNT7B mRNA |
CTD |
PMID:32234424 PMID:35690182 |
|
NCBI chr 7:116,634,817...116,679,459
Ensembl chr 7:116,634,814...116,679,581
|
|
G |
Wwox |
WW domain-containing oxidoreductase |
decreases expression |
ISO |
lasiocarpine results in decreased expression of WWOX mRNA |
CTD |
PMID:32234424 PMID:35690182 |
|
NCBI chr19:42,432,141...43,360,278
Ensembl chr19:42,432,152...43,359,391
|
|
|
G |
Il6 |
interleukin 6 |
increases expression |
ISO |
licofelone results in increased expression of IL6 mRNA |
CTD |
PMID:17766677 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
|
G |
H2ax |
H2A.X variant histone |
increases expression |
ISO |
otosenine results in increased expression of H2AX protein |
CTD |
PMID:31154085 |
|
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239 Ensembl chr 4:44,671,786...44,673,239
|
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
increases expression |
EXP |
riddelliine results in increased expression of ABCB1 mRNA; riddelliine results in increased expression of ABCB1A mRNA |
CTD |
PMID:18047722 PMID:18047727 |
|
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Abcb9 |
ATP binding cassette subfamily B member 9 |
decreases expression |
EXP |
riddelliine results in decreased expression of ABCB9 mRNA |
CTD |
PMID:18047722 |
|
NCBI chr12:32,499,213...32,531,932
Ensembl chr12:32,499,225...32,531,931
|
|
G |
Abcc3 |
ATP binding cassette subfamily C member 3 |
increases expression |
EXP |
riddelliine results in increased expression of ABCC3 mRNA |
CTD |
PMID:18047722 PMID:18047727 |
|
NCBI chr10:79,296,681...79,342,749
Ensembl chr10:79,296,693...79,342,595
|
|
G |
Abcc8 |
ATP binding cassette subfamily C member 8 |
decreases expression |
EXP |
riddelliine results in decreased expression of ABCC8 mRNA |
CTD |
PMID:18047722 PMID:18047727 |
|
NCBI chr 1:96,598,568...96,679,563
Ensembl chr 1:96,598,647...96,679,510
|
|
G |
Abcc9 |
ATP binding cassette subfamily C member 9 |
decreases expression |
EXP |
riddelliine results in decreased expression of ABCC9 mRNA |
CTD |
PMID:18047727 |
|
NCBI chr 4:175,531,854...175,655,849
Ensembl chr 4:175,532,547...175,655,356
|
|
G |
Adm |
adrenomedullin |
decreases expression |
EXP |
riddelliine results in decreased expression of ADM mRNA |
CTD |
PMID:18047727 |
|
NCBI chr 1:164,745,484...164,747,655
Ensembl chr 1:164,745,466...164,747,654
|
|
G |
Ahr |
aryl hydrocarbon receptor |
increases expression |
EXP |
riddelliine results in increased expression of AHR mRNA |
CTD |
PMID:18047727 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Anapc1 |
anaphase promoting complex subunit 1 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of ANAPC1 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 3:115,850,117...115,930,259
Ensembl chr 3:115,850,185...115,930,273
|
|
G |
Arid2 |
AT-rich interaction domain 2 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of ARID2 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 7:127,447,192...127,565,987
Ensembl chr 7:127,447,278...127,563,512
|
|
G |
Atp13a5 |
ATPase 13A5 |
decreases expression |
EXP |
riddelliine results in decreased expression of ATP13A5 mRNA |
CTD |
PMID:18047722 |
|
NCBI chr11:71,376,388...71,515,789
Ensembl chr11:71,376,422...71,515,789
|
|
G |
Aurka |
aurora kinase A |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of AURKA mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 3:161,128,309...161,144,524
Ensembl chr 3:161,128,313...161,144,390
|
|
G |
Babam2 |
BRISC and BRCA1 A complex member 2 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of riddelliine] which results in increased expression of BABAM2 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 6:24,369,021...24,788,416
Ensembl chr 6:24,369,022...24,833,951
|
|
G |
Bard1 |
BRCA1 associated RING domain 1 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of BARD1 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 9:72,616,070...72,694,553
Ensembl chr 9:72,623,155...72,694,265
|
|
G |
Blm |
BLM RecQ like helicase |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of BLM mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 1:134,409,832...134,496,073
Ensembl chr 1:134,409,857...134,484,312
|
|
G |
Bora |
bora, aurora kinase A activator |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of BORA mRNA |
CTD |
PMID:33884520 |
|
NCBI chr15:75,797,624...75,835,599
Ensembl chr15:75,797,891...75,821,322
|
|
G |
Brca1 |
BRCA1, DNA repair associated |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of BRCA1 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr10:86,417,441...86,477,762
Ensembl chr10:86,418,000...86,477,304
|
|
G |
Brca2 |
BRCA2, DNA repair associated |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of BRCA2 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr12:59,492...103,789
Ensembl chr12:59,819...100,567
|
|
G |
Brip1 |
BRCA1 interacting DNA helicase 1 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of BRIP1 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr10:70,907,266...71,031,502
Ensembl chr10:70,907,371...71,030,324
|
|
G |
Ccnb1 |
cyclin B1 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of CCNB1 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Ccnb2 |
cyclin B2 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of CCNB2 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 8:71,087,594...71,100,794
Ensembl chr 8:71,087,595...71,100,874
|
|
G |
Cdc20 |
cell division cycle 20 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of CDC20 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 5:131,966,203...131,970,406
Ensembl chr 5:131,966,215...131,970,512
|
|
G |
Cdc23 |
cell division cycle 23 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of CDC23 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr18:26,236,891...26,260,611
Ensembl chr18:26,236,890...26,291,163
|
|
G |
Cdc25a |
cell division cycle 25A |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of CDC25A mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 8:109,864,356...109,882,734
Ensembl chr 8:109,864,478...109,882,701
|
|
G |
Cdc25b |
cell division cycle 25B |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of CDC25B mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 3:118,407,127...118,417,272
Ensembl chr 3:118,407,128...118,417,272
|
|
G |
Cdc25c |
cell division cycle 25C |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of CDC25C mRNA |
CTD |
PMID:33884520 |
|
NCBI chr18:26,335,156...26,356,199
Ensembl chr18:26,335,834...26,356,185
|
|
G |
Cdk1 |
cyclin-dependent kinase 1 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of CDK1 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
|
|
G |
Cdk2 |
cyclin dependent kinase 2 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of CDK2 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of riddelliine] which results in increased expression of CDKN1A mRNA |
CTD |
PMID:33884520 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Ces2h |
carboxylesterase 2H |
increases expression |
EXP |
riddelliine results in increased expression of CES2 mRNA |
CTD |
PMID:18047722 |
|
NCBI chr19:32,974,242...32,988,842
Ensembl chr19:32,974,242...32,988,830
|
|
G |
Chek1 |
checkpoint kinase 1 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of CHEK1 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 8:36,420,565...36,443,477
Ensembl chr 8:36,420,569...36,441,009
|
|
G |
Clspn |
claspin |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of CLSPN mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 5:138,850,119...138,885,037
Ensembl chr 5:138,850,128...138,885,034
|
|
G |
Cxcr1 |
C-X-C motif chemokine receptor 1 |
increases expression |
EXP |
riddelliine results in increased expression of CXCR1 mRNA |
CTD |
PMID:18047727 |
|
NCBI chr 9:75,766,894...75,771,079
Ensembl chr 9:75,766,770...75,771,084
|
|
G |
Cyp26a1 |
cytochrome P450, family 26, subfamily a, polypeptide 1 |
increases expression |
EXP |
riddelliine results in increased expression of CYP26A1 mRNA |
CTD |
PMID:18047727 |
|
NCBI chr 1:235,471,368...235,475,204
Ensembl chr 1:235,471,298...235,475,204
|
|
G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
decreases expression |
EXP |
riddelliine results in decreased expression of CYP2C mRNA |
CTD |
PMID:18047722 PMID:18047727 |
|
NCBI chr 1:236,762,719...236,799,069
Ensembl chr 1:236,762,842...236,799,066
|
|
G |
Cyp2c12 |
cytochrome P450, family 2, subfamily c, polypeptide 12 |
increases expression |
EXP |
riddelliine results in increased expression of CYP2C12 mRNA |
CTD |
PMID:18047727 |
|
NCBI chr 1:238,699,859...238,757,011
Ensembl chr 1:238,699,854...238,757,019
|
|
G |
Cyp2c13 |
cytochrome P450, family 2, subfamily c, polypeptide 13 |
decreases expression |
EXP |
riddelliine results in decreased expression of CYP2C13 mRNA |
CTD |
PMID:18047727 |
|
NCBI chr 1:238,786,764...238,867,195
Ensembl chr 1:238,786,765...238,867,191
|
|
G |
Cyp2c22 |
cytochrome P450, family 2, subfamily c, polypeptide 22 |
decreases expression |
EXP |
riddelliine results in decreased expression of CYP2C22 mRNA |
CTD |
PMID:18047727 |
|
NCBI chr 1:238,991,698...239,031,323
Ensembl chr 1:238,991,610...239,021,738
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
increases expression |
EXP |
riddelliine results in increased expression of CYP2E1 mRNA |
CTD |
PMID:18047722 PMID:18047727 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Cyp3a18 |
cytochrome P450, family 3, subfamily a, polypeptide 18 |
decreases expression |
EXP |
riddelliine results in decreased expression of CYP3A18 mRNA |
CTD |
PMID:18047727 |
|
NCBI chr12:8,880,509...8,930,382
Ensembl chr12:8,880,528...8,930,381
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
decreases expression increases response to substance multiple interactions increases metabolic processing |
EXP ISO |
riddelliine results in decreased expression of CYP3A2 mRNA CYP3A4 protein results in increased susceptibility to riddelliine [CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of ANAPC1 mRNA; [CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of ARID2 mRNA; [CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of ATRIP mRNA; [CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of AURKA mRNA; [CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of BARD1 mRNA; [CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of BLM mRNA; [CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of BORA mRNA; [CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of BRCA1 mRNA; [CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of BRCA2 mRNA; [CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of BRIP1 mRNA; [CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of CCNB1 mRNA; [CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of CCNB2 mRNA; [CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of CDC20 mRNA; [CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of CDC23 mRNA; [CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of CDC25A mRNA; [CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of CDC25B mRNA; [CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of CDC25C mRNA; [CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of CDK1 mRNA; [CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of CDK2 mRNA; [CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of CHEK1 mRNA; [CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of CLSPN mRNA; [CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of E2F1 mRNA; [CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of E2F5 mRNA; [CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of E2F8 mRNA; [CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of ESPL1 mRNA; [CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of FANCA mRNA; [CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of FANCB mRNA; [CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of FANCC mRNA; [CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of FANCD2 mRNA; [CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of FBXO5 mRNA; [CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of KIF11 mRNA; [CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of KIF23 mRNA; [CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of MDC1 mRNA; [CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of MRE11 mRNA; [CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of MSH2 mRNA; [CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of MSH6 mRNA; [CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of NBN mRNA; [CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of PBRM1 mRNA; [CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of PHF10 mRNA; [CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of PKMYT1 mRNA; [CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of PLK1 mRNA; [CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of PLK4 mRNA; [CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of POU2F1 mRNA; [CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of PPM1L mRNA; [CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of PPP2R1B mRNA; [CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of PPP2R2A mRNA; [CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of PRC1 mRNA; [CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of PTTG1 mRNA; [CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of RAD1 mRNA; [CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of RAD21 mRNA; [CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of RBBP8 mRNA; [CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of RBL1 mRNA; [CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of RBL2 mRNA; [CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of RFC1 mRNA; [CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of RFC2 mRNA; [CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of RFC3 mRNA; [CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of RFC4 mRNA; [CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of RFC5 mRNA; [CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of RPA1 mRNA; [CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of SMARCC1 mRNA; [CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of SMC3 mRNA; [CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of STAG2 mRNA; [CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of TLK1 mRNA; [CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of TOP2A mRNA; [CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of TOPBP1 mRNA; [CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of WEE1 mRNA; [CYP3A4 protein results in increased metabolism of riddelliine] which results in increased expression of BABAM2 mRNA; [CYP3A4 protein results in increased metabolism of riddelliine] which results in increased expression of CDKN1A mRNA; [CYP3A4 protein results in increased metabolism of riddelliine] which results in increased expression of GADD45A mRNA; [CYP3A4 protein results in increased metabolism of riddelliine] which results in increased expression of PLK2 mRNA; [CYP3A4 protein results in increased metabolism of riddelliine] which results in increased expression of PLK3 mRNA; [CYP3A4 protein results in increased metabolism of riddelliine] which results in increased expression of PPP2CB mRNA; [CYP3A4 protein results in increased metabolism of riddelliine] which results in increased expression of SMARCA2 mRNA; [CYP3A4 protein results in increased metabolism of riddelliine] which results in increased expression of STAT1 mRNA |
CTD |
PMID:18047727 PMID:32910235 PMID:33884520 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
increases expression |
EXP |
riddelliine results in increased expression of CYP3A9 mRNA |
CTD |
PMID:18047727 |
|
NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422
|
|
G |
Cyp4a8 |
cytochrome P450, family 4, subfamily a, polypeptide 8 |
decreases expression |
EXP |
riddelliine results in decreased expression of CYP4A8 mRNA |
CTD |
PMID:18047727 |
|
NCBI chr 5:128,702,130...128,733,476
Ensembl chr 5:128,702,131...128,733,476
|
|
G |
E2f1 |
E2F transcription factor 1 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of E2F1 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 3:143,064,535...143,075,362
Ensembl chr 3:143,049,478...143,075,361
|
|
G |
E2f5 |
E2F transcription factor 5 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of E2F5 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 2:86,997,331...87,012,908
Ensembl chr 2:86,997,332...87,012,990
|
|
G |
E2f8 |
E2F transcription factor 8 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of E2F8 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 1:98,565,717...98,584,265
Ensembl chr 1:98,565,717...98,584,098
|
|
G |
Egr1 |
early growth response 1 |
increases expression |
EXP |
riddelliine results in increased expression of EGR1 mRNA |
CTD |
PMID:18047727 |
|
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
|
|
G |
Enpp2 |
ectonucleotide pyrophosphatase/phosphodiesterase 2 |
decreases expression |
EXP |
riddelliine results in decreased expression of ENPP2 mRNA |
CTD |
PMID:18047727 |
|
NCBI chr 7:86,202,345...86,325,050
Ensembl chr 7:86,202,350...86,324,827
|
|
G |
Espl1 |
extra spindle pole bodies like 1, separase |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of ESPL1 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 7:133,424,027...133,450,984
Ensembl chr 7:133,424,130...133,450,984
|
|
G |
F11r |
F11 receptor |
decreases expression |
EXP |
riddelliine results in decreased expression of F11R mRNA |
CTD |
PMID:18047727 |
|
NCBI chr13:83,873,797...83,897,388
Ensembl chr13:83,873,797...83,897,402
|
|
G |
F3 |
coagulation factor III, tissue factor |
decreases expression |
EXP |
riddelliine results in decreased expression of F3 mRNA |
CTD |
PMID:18047727 |
|
NCBI chr 2:209,827,061...209,838,666
Ensembl chr 2:209,826,959...209,838,668
|
|
G |
F7 |
coagulation factor VII |
increases expression |
EXP |
riddelliine results in increased expression of F7 mRNA |
CTD |
PMID:18047727 |
|
NCBI chr16:76,489,775...76,500,636
Ensembl chr16:76,489,717...76,500,610
|
|
G |
Fanca |
FA complementation group A |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of FANCA mRNA |
CTD |
PMID:33884520 |
|
NCBI chr19:51,304,126...51,362,586
Ensembl chr19:51,304,021...51,362,527
|
|
G |
Fancb |
FA complementation group B |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of FANCB mRNA |
CTD |
PMID:33884520 |
|
NCBI chr X:29,403,771...29,420,484
Ensembl chr X:29,403,771...29,420,192
|
|
G |
Fancc |
FA complementation group C |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of FANCC mRNA |
CTD |
PMID:33884520 |
|
NCBI chr17:1,680,660...1,822,610
Ensembl chr17:1,681,324...1,829,376
|
|
G |
Fancd2 |
FA complementation group D2 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of FANCD2 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 4:146,679,014...146,743,422
Ensembl chr 4:146,679,179...146,743,412
|
|
G |
Fas |
Fas cell surface death receptor |
increases expression |
EXP |
riddelliine results in increased expression of FAS mRNA |
CTD |
PMID:18047727 |
|
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Fbxo5 |
F-box protein 5 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of FBXO5 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 1:42,196,068...42,202,437
Ensembl chr 1:42,196,068...42,202,437
|
|
G |
Fmo5 |
flavin containing dimethylaniline monoxygenase 5 |
increases expression |
EXP |
riddelliine results in increased expression of FMO5 mRNA |
CTD |
PMID:18047722 |
|
NCBI chr 2:185,197,184...185,249,699
Ensembl chr 2:185,222,204...185,249,693
|
|
G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of riddelliine] which results in increased expression of GADD45A mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115
|
|
G |
Gsta3 |
glutathione S-transferase alpha 3 |
increases expression |
EXP |
riddelliine results in increased expression of GSTA3 mRNA |
CTD |
PMID:18047722 PMID:18047727 |
|
NCBI chr 9:23,658,574...23,684,240
Ensembl chr 9:23,658,574...23,684,240
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
decreases expression |
EXP |
riddelliine results in decreased expression of GSTM1 mRNA |
CTD |
PMID:18047727 |
|
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
|
|
G |
Gstm2 |
glutathione S-transferase mu 2 |
decreases expression |
EXP |
riddelliine results in decreased expression of GSTM2 mRNA |
CTD |
PMID:18047727 |
|
NCBI chr 2:195,624,015...195,628,774
Ensembl chr 2:195,544,426...195,628,961
|
|
G |
H2ax |
H2A.X variant histone |
increases phosphorylation increases expression |
EXP ISO |
riddelliine results in increased phosphorylation of H2AX protein riddelliine results in increased expression of H2AX protein |
CTD |
PMID:31154085 PMID:31289892 |
|
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239 Ensembl chr 4:44,671,786...44,673,239
|
|
G |
Hgf |
hepatocyte growth factor |
increases expression |
EXP |
riddelliine results in increased expression of HGF mRNA |
CTD |
PMID:18047727 |
|
NCBI chr 4:18,673,736...18,745,582
Ensembl chr 4:18,677,101...18,745,409
|
|
G |
Igfbp1 |
insulin-like growth factor binding protein 1 |
increases expression |
EXP |
riddelliine results in increased expression of IGFBP1 mRNA |
CTD |
PMID:18047727 |
|
NCBI chr14:82,047,415...82,052,482
Ensembl chr14:82,047,415...82,052,482
|
|
G |
Igfbp2 |
insulin-like growth factor binding protein 2 |
increases expression |
EXP |
riddelliine results in increased expression of IGFBP2 mRNA |
CTD |
PMID:18047727 |
|
NCBI chr 9:74,415,574...74,442,945
Ensembl chr 9:74,415,546...74,442,937
|
|
G |
Il11 |
interleukin 11 |
increases expression |
EXP |
riddelliine results in increased expression of IL11 mRNA |
CTD |
PMID:18047727 |
|
NCBI chr 1:69,069,829...69,076,129
Ensembl chr 1:69,068,137...69,076,129
|
|
G |
Il15 |
interleukin 15 |
increases expression |
EXP |
riddelliine results in increased expression of IL15 mRNA |
CTD |
PMID:18047727 |
|
NCBI chr19:25,640,025...25,706,818
Ensembl chr19:25,640,251...25,706,820
|
|
G |
Il7 |
interleukin 7 |
decreases expression |
EXP |
riddelliine results in decreased expression of IL7 mRNA |
CTD |
PMID:18047727 |
|
NCBI chr 2:94,235,219...94,280,075
Ensembl chr 2:94,234,766...94,280,075
|
|
G |
Inmt |
indolethylamine N-methyltransferase |
decreases expression |
EXP |
riddelliine results in decreased expression of INMT mRNA |
CTD |
PMID:18047722 |
|
NCBI chr 4:84,318,197...84,322,493
Ensembl chr 4:84,318,197...84,322,493
|
|
G |
Itga4 |
integrin subunit alpha 4 |
increases expression |
EXP |
riddelliine results in increased expression of ITGA4 mRNA |
CTD |
PMID:18047727 |
|
NCBI chr 3:64,162,764...64,235,010
Ensembl chr 3:64,163,085...64,233,715
|
|
G |
Itga6 |
integrin subunit alpha 6 |
decreases expression |
EXP |
riddelliine results in decreased expression of ITGA6 mRNA |
CTD |
PMID:18047727 |
|
NCBI chr 3:56,604,512...56,689,428
Ensembl chr 3:56,617,268...56,689,428
|
|
G |
Kdr |
kinase insert domain receptor |
multiple interactions increases expression |
EXP |
riddelliine results in increased phosphorylation of and results in increased activity of KDR protein riddelliine results in increased expression of KDR protein |
CTD |
PMID:12460743 PMID:15384251 |
|
NCBI chr14:32,217,871...32,261,018
Ensembl chr14:32,217,871...32,261,018
|
|
G |
Kif11 |
kinesin family member 11 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of KIF11 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 1:235,124,371...235,176,760
Ensembl chr 1:235,124,316...235,176,766
|
|
G |
Kif23 |
kinesin family member 23 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of KIF23 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 8:62,397,908...62,425,162
Ensembl chr 8:62,397,948...62,425,072
|
|
G |
Kras |
KRAS proto-oncogene, GTPase |
increases mutagenesis |
ISO |
riddelliine results in increased mutagenesis of KRAS gene |
CTD |
PMID:13678655 PMID:20737008 |
|
NCBI chr 4:178,185,418...178,218,484
|
|
G |
Lepr |
leptin receptor |
increases expression |
EXP |
riddelliine results in increased expression of LEPR mRNA |
CTD |
PMID:18047727 |
|
NCBI chr 5:116,294,409...116,477,904
Ensembl chr 5:116,289,823...116,475,908
|
|
G |
Mdc1 |
mediator of DNA damage checkpoint 1 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of MDC1 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr20:2,893,693...2,912,394
Ensembl chr20:2,895,505...2,910,240
|
|
G |
Mmp7 |
matrix metallopeptidase 7 |
decreases expression |
EXP |
riddelliine results in decreased expression of MMP7 mRNA |
CTD |
PMID:18047727 |
|
NCBI chr 8:4,848,186...4,855,908
Ensembl chr 8:4,848,186...4,855,902
|
|
G |
Mre11 |
MRE11 homolog, double strand break repair nuclease |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of MRE11 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 8:11,618,876...11,680,451
Ensembl chr 8:11,632,354...11,678,279
|
|
G |
Msh2 |
mutS homolog 2 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of MSH2 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 6:6,813,793...6,872,960
Ensembl chr 6:6,813,795...6,872,938
|
|
G |
Msh6 |
mutS homolog 6 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of MSH6 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 6:6,562,631...6,579,995
Ensembl chr 6:6,562,632...6,579,956
|
|
G |
Mt1 |
metallothionein 1 |
increases expression |
EXP |
riddelliine results in increased expression of MT1A mRNA |
CTD |
PMID:18047727 |
|
NCBI chr19:10,826,032...10,827,048
Ensembl chr19:10,826,032...10,827,049 Ensembl chr17:10,826,032...10,827,049 Ensembl chr X:10,826,032...10,827,049
|
|
G |
Mthfd2 |
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase |
decreases expression |
EXP |
riddelliine results in decreased expression of MTHFD2 mRNA |
CTD |
PMID:18047727 |
|
NCBI chr 4:115,811,135...115,822,663
Ensembl chr 4:115,811,139...115,822,608
|
|
G |
Nbn |
nibrin |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of NBN mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 5:29,459,574...29,494,152
Ensembl chr 5:29,459,457...29,494,150
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
increases expression |
EXP |
riddelliine results in increased expression of NQO1 mRNA |
CTD |
PMID:18047722 PMID:18047727 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Pbrm1 |
polybromo 1 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of PBRM1 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr16:6,213,507...6,312,895
Ensembl chr16:6,213,300...6,311,780
|
|
G |
Phf10 |
PHD finger protein 10 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of PHF10 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 1:55,952,249...55,968,994
Ensembl chr 1:55,952,253...55,969,038
|
|
G |
Pkmyt1 |
protein kinase, membrane associated tyrosine/threonine 1 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of PKMYT1 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr10:12,748,221...12,758,995
Ensembl chr10:12,748,237...12,758,995
|
|
G |
Plk1 |
polo-like kinase 1 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of PLK1 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 1:176,716,420...176,726,400
Ensembl chr 1:176,716,420...176,726,400
|
|
G |
Plk2 |
polo-like kinase 2 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of riddelliine] which results in increased expression of PLK2 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 2:41,969,176...41,974,945
Ensembl chr 2:41,969,176...41,974,947
|
|
G |
Plk3 |
polo-like kinase 3 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of riddelliine] which results in increased expression of PLK3 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 5:130,607,142...130,612,317
Ensembl chr 5:130,607,142...130,612,317
|
|
G |
Plk4 |
polo-like kinase 4 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of PLK4 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 2:123,802,527...123,820,942
Ensembl chr 2:123,802,512...123,820,942
|
|
G |
Pou2f1 |
POU class 2 homeobox 1 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of POU2F1 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr13:78,120,617...78,263,306
Ensembl chr13:78,130,685...78,263,363
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
decreases expression |
EXP |
riddelliine results in decreased expression of PPARG mRNA |
CTD |
PMID:18047727 |
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Ppm1l |
protein phosphatase, Mg2+/Mn2+ dependent, 1L |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of PPM1L mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 2:153,566,653...153,839,434
Ensembl chr 2:153,566,653...153,839,434
|
|
G |
Ppp2cb |
protein phosphatase 2 catalytic subunit beta |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of riddelliine] which results in increased expression of PPP2CB mRNA |
CTD |
PMID:33884520 |
|
NCBI chr16:58,558,119...58,579,325
Ensembl chr16:58,558,122...58,579,576
|
|
G |
Ppp2r1b |
protein phosphatase 2 scaffold subunit A beta |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of PPP2R1B mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 8:51,195,860...51,228,442
Ensembl chr 8:51,186,717...51,228,485
|
|
G |
Ppp2r2a |
protein phosphatase 2, regulatory subunit B, alpha |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of PPP2R2A mRNA |
CTD |
PMID:33884520 |
|
NCBI chr15:41,204,659...41,263,924
Ensembl chr15:41,204,200...41,263,924
|
|
G |
Prc1 |
protein regulator of cytokinesis 1 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of PRC1 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 1:134,250,086...134,271,765
Ensembl chr 1:134,250,081...134,271,765
|
|
G |
Prkca |
protein kinase C, alpha |
increases expression |
EXP |
riddelliine results in increased expression of PRKCA mRNA |
CTD |
PMID:18047727 |
|
NCBI chr10:92,889,390...93,288,013
Ensembl chr10:92,894,012...93,288,012
|
|
G |
Prkcz |
protein kinase C, zeta |
increases expression |
EXP |
riddelliine results in increased expression of PRKCZ mRNA |
CTD |
PMID:18047727 |
|
NCBI chr 5:165,817,786...165,930,386
Ensembl chr 5:165,819,466...165,930,367
|
|
G |
Pttg1 |
PTTG1 regulator of sister chromatid separation, securin |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of PTTG1 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr10:27,893,466...27,904,965
Ensembl chr10:27,893,689...27,904,837
|
|
G |
Rad1 |
RAD1 checkpoint DNA exonuclease |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of RAD1 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 2:59,461,597...59,469,707
Ensembl chr 2:59,461,607...59,469,689
|
|
G |
Rad21 |
RAD21 cohesin complex component |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of RAD21 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 7:83,287,867...83,314,810
Ensembl chr 7:83,287,870...83,314,817
|
|
G |
Rbbp8 |
RB binding protein 8, endonuclease |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of RBBP8 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr18:2,922,985...2,988,851
Ensembl chr18:2,921,286...2,988,846
|
|
G |
Rbl1 |
RB transcriptional corepressor like 1 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of RBL1 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 3:145,806,160...145,869,434
Ensembl chr 3:145,807,095...145,869,330
|
|
G |
Rbl2 |
RB transcriptional corepressor like 2 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of RBL2 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr19:15,876,852...15,923,632
Ensembl chr19:15,876,853...15,923,572
|
|
G |
Ren |
renin |
increases expression |
EXP |
riddelliine results in increased expression of REN mRNA |
CTD |
PMID:18047727 |
|
NCBI chr13:44,796,260...44,807,491
Ensembl chr13:44,796,091...44,807,489
|
|
G |
Rfc1 |
replication factor C subunit 1 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of RFC1 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr14:42,966,279...43,041,372
Ensembl chr14:42,966,324...43,041,370
|
|
G |
Rfc2 |
replication factor C subunit 2 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of RFC2 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr12:22,120,449...22,133,576
Ensembl chr12:22,120,010...22,133,557
|
|
G |
Rfc3 |
replication factor C subunit 3 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of RFC3 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr12:1,000,987...1,011,778
Ensembl chr12:1,000,994...1,011,778
|
|
G |
Rfc4 |
replication factor C subunit 4 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of RFC4 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr11:77,749,642...77,764,123
Ensembl chr11:77,749,638...77,764,122
|
|
G |
Rfc5 |
replication factor C subunit 5 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of RFC5 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr12:39,207,484...39,217,041
Ensembl chr12:39,207,484...39,217,312
|
|
G |
Rpa1 |
replication protein A1 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of RPA1 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr10:60,148,869...60,199,970
Ensembl chr10:60,148,793...60,199,949
|
|
G |
S1pr2 |
sphingosine-1-phosphate receptor 2 |
decreases expression |
EXP |
riddelliine results in decreased expression of S1PR2 mRNA |
CTD |
PMID:18047727 |
|
NCBI chr 8:19,503,276...19,514,169
Ensembl chr 8:19,502,627...19,523,574
|
|
G |
Slc13a5 |
solute carrier family 13 member 5 |
decreases expression |
EXP |
riddelliine results in decreased expression of SLC13A5 mRNA |
CTD |
PMID:18047722 |
|
NCBI chr10:56,866,249...56,891,189
Ensembl chr10:56,866,249...56,890,945
|
|
G |
Slc16a4 |
solute carrier family 16, member 4 |
decreases expression |
EXP |
riddelliine results in decreased expression of SLC16A4 mRNA |
CTD |
PMID:18047722 |
|
NCBI chr 2:194,911,075...194,933,162
Ensembl chr 2:194,911,236...194,933,117
|
|
G |
Slc22a6 |
solute carrier family 22 member 6 |
decreases expression |
EXP |
riddelliine results in decreased expression of SLC22A6 mRNA |
CTD |
PMID:18047722 |
|
NCBI chr 1:205,522,579...205,531,179
Ensembl chr 1:205,522,729...205,531,173
|
|
G |
Slc22a8 |
solute carrier family 22 member 8 |
decreases expression |
EXP |
riddelliine results in decreased expression of SLC22A8 mRNA |
CTD |
PMID:18047722 |
|
NCBI chr 1:205,496,331...205,516,378
Ensembl chr 1:205,498,084...205,517,450
|
|
G |
Slc25a21 |
solute carrier family 25 member 21 |
increases expression |
EXP |
riddelliine results in increased expression of SLC25A21 mRNA |
CTD |
PMID:18047722 |
|
NCBI chr 6:74,203,439...74,702,902
Ensembl chr 6:74,203,440...74,702,680
|
|
G |
Slc25a30 |
solute carrier family 25, member 30 |
decreases expression |
EXP |
riddelliine results in decreased expression of SLC25A30 mRNA |
CTD |
PMID:18047722 |
|
NCBI chr15:51,076,998...51,099,613
Ensembl chr15:51,077,002...51,099,613
|
|
G |
Slc7a5 |
solute carrier family 7 member 5 |
increases expression |
EXP |
riddelliine results in increased expression of SLC7A5 mRNA |
CTD |
PMID:18047727 |
|
NCBI chr19:49,935,220...49,963,823
Ensembl chr19:49,935,220...49,963,823
|
|
G |
Smarca2 |
SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of riddelliine] which results in increased expression of SMARCA2 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 1:224,191,125...224,358,640
Ensembl chr 1:224,191,125...224,358,684
|
|
G |
Smarcc1 |
SWI/SNF related BAF chromatin remodeling complex subunit C1 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of SMARCC1 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 8:110,111,097...110,214,734
Ensembl chr 8:110,111,122...110,214,720
|
|
G |
Smc3 |
structural maintenance of chromosomes 3 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of SMC3 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 1:252,601,422...252,644,522
Ensembl chr 1:252,601,753...252,644,522
|
|
G |
Src |
SRC proto-oncogene, non-receptor tyrosine kinase |
increases expression |
EXP |
riddelliine results in increased expression of SRC mRNA |
CTD |
PMID:18047727 |
|
NCBI chr 3:146,091,969...146,139,492
Ensembl chr 3:146,091,841...146,139,476
|
|
G |
Stag2 |
STAG2 cohesin complex component |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of STAG2 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr X:120,974,687...121,105,677
Ensembl chr X:120,974,857...121,105,677
|
|
G |
Stat1 |
signal transducer and activator of transcription 1 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of riddelliine] which results in increased expression of STAT1 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 9:49,419,561...49,459,969
Ensembl chr 9:49,419,340...49,588,540
|
|
G |
Sult1c3 |
sulfotransferase family 1C member 3 |
decreases expression |
EXP |
riddelliine results in decreased expression of SULT1C1 mRNA |
CTD |
PMID:18047722 |
|
NCBI chr 9:7,221,580...7,266,991
Ensembl chr 9:7,221,578...7,267,030
|
|
G |
Tgfa |
transforming growth factor alpha |
decreases expression |
EXP |
riddelliine results in decreased expression of TGFA mRNA |
CTD |
PMID:18047727 |
|
NCBI chr 4:118,618,043...118,700,897
Ensembl chr 4:118,618,269...118,700,894
|
|
G |
Tlk1 |
tousled-like kinase 1 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of TLK1 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 3:55,520,559...55,627,580
Ensembl chr 3:55,503,358...55,691,968
|
|
G |
Tnf |
tumor necrosis factor |
decreases expression |
EXP |
riddelliine results in decreased expression of TNF mRNA |
CTD |
PMID:18047727 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfsf10 |
TNF superfamily member 10 |
increases expression |
EXP |
riddelliine results in increased expression of TNFSF10 mRNA |
CTD |
PMID:18047727 |
|
NCBI chr 2:110,199,835...110,227,239
Ensembl chr 2:110,207,916...110,225,135
|
|
G |
Top2a |
DNA topoisomerase II alpha |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of TOP2A mRNA |
CTD |
PMID:33884520 |
|
NCBI chr10:83,945,731...83,976,874
Ensembl chr10:83,945,735...83,976,874
|
|
G |
Topbp1 |
DNA topoisomerase II binding protein 1 |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of TOPBP1 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 8:103,887,805...103,931,662
Ensembl chr 8:103,887,865...103,931,674
|
|
G |
Tp53 |
tumor protein p53 |
increases expression increases mutagenesis |
EXP ISO |
riddelliine results in increased expression of TP53 protein riddelliine results in increased mutagenesis of TRP53 gene |
CTD |
PMID:12460743 PMID:13678655 PMID:20737008 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Wee1 |
WEE1 G2 checkpoint kinase |
multiple interactions |
ISO |
[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of WEE1 mRNA |
CTD |
PMID:33884520 |
|
NCBI chr 1:164,173,681...164,197,688
Ensembl chr 1:164,174,779...164,197,688
|
|
|
G |
Abca3 |
ATP binding cassette subfamily A member 3 |
decreases expression |
ISO |
senecionine results in decreased expression of ABCA3 protein |
CTD |
PMID:35357534 |
|
NCBI chr10:13,382,439...13,439,748
Ensembl chr10:13,382,540...13,439,745
|
|
G |
Abcb11 |
ATP binding cassette subfamily B member 11 |
decreases expression |
ISO |
senecionine results in decreased expression of ABCB11 mRNA |
CTD |
PMID:26100227 PMID:31606820 |
|
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
decreases expression |
ISO |
senecionine results in decreased expression of ABCB1 mRNA |
CTD |
PMID:31606820 |
|
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Abcb1b |
ATP-binding cassette, sub-family B member 1B |
increases expression |
EXP |
senecionine results in increased expression of ABCB1B mRNA |
CTD |
PMID:32419051 |
|
NCBI chr 4:25,242,761...25,325,194
Ensembl chr 4:25,242,798...25,325,199
|
|
G |
Abcb4 |
ATP binding cassette subfamily B member 4 |
decreases expression |
ISO |
senecionine results in decreased expression of ABCB4 mRNA |
CTD |
PMID:31606820 |
|
NCBI chr 4:25,150,998...25,209,489
Ensembl chr 4:25,151,953...25,209,202
|
|
G |
Abcc1 |
ATP binding cassette subfamily C member 1 |
increases expression |
ISO |
senecionine results in increased expression of ABCC1 mRNA |
CTD |
PMID:31606820 |
|
NCBI chr10:528,961...655,179
Ensembl chr10:531,812...655,114
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
decreases expression |
ISO |
senecionine results in decreased expression of ABCC2 mRNA |
CTD |
PMID:26100227 PMID:31606820 |
|
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
|
|
G |
Abcc3 |
ATP binding cassette subfamily C member 3 |
increases expression decreases expression |
EXP ISO |
senecionine results in increased expression of ABCC3 mRNA senecionine results in decreased expression of ABCC3 mRNA |
CTD |
PMID:24641316 PMID:26100227 PMID:31606820 |
|
NCBI chr10:79,296,681...79,342,749
Ensembl chr10:79,296,693...79,342,595
|
|
G |
Abcc4 |
ATP binding cassette subfamily C member 4 |
decreases expression |
ISO |
senecionine results in decreased expression of ABCC4 mRNA |
CTD |
PMID:31606820 |
|
NCBI chr15:95,541,186...95,774,898
Ensembl chr15:95,542,315...95,774,283
|
|
G |
Abcc6 |
ATP binding cassette subfamily C member 6 |
decreases expression |
ISO |
senecionine results in decreased expression of ABCC6 mRNA |
CTD |
PMID:26100227 |
|
NCBI chr 1:96,447,224...96,501,464
Ensembl chr 1:96,447,251...96,501,464
|
|
G |
Abhd11 |
abhydrolase domain containing 11 |
increases expression |
ISO |
senecionine results in increased expression of ABHD11 protein |
CTD |
PMID:35357534 |
|
NCBI chr12:21,682,206...21,685,331
Ensembl chr12:21,682,202...21,685,398
|
|
G |
Abtb2 |
ankyrin repeat and BTB domain containing 2 |
increases expression |
ISO |
senecionine results in increased expression of ABTB2 protein |
CTD |
PMID:35357534 |
|
NCBI chr 3:89,954,726...90,108,549
Ensembl chr 3:89,954,713...90,108,548
|
|
G |
Acaa1a |
acetyl-CoA acyltransferase 1A |
increases expression |
ISO |
senecionine results in increased expression of ACAA1A protein |
CTD |
PMID:35357534 |
|
NCBI chr 8:119,079,401...119,088,626
Ensembl chr 8:119,079,775...119,088,624
|
|
G |
Acaa1b |
acetyl-Coenzyme A acyltransferase 1B |
increases expression |
ISO |
senecionine results in increased expression of ACAA1B protein |
CTD |
PMID:35357534 |
|
NCBI chr 8:118,872,996...118,881,852
Ensembl chr 8:118,872,997...118,881,825
|
|
G |
Acot13 |
acyl-CoA thioesterase 13 |
increases expression |
ISO |
senecionine results in increased expression of ACOT13 protein |
CTD |
PMID:35357534 |
|
NCBI chr17:40,240,378...40,252,851
Ensembl chr17:40,240,378...40,252,851
|
|
G |
Acot2 |
acyl-CoA thioesterase 2 |
increases expression |
ISO |
senecionine results in increased expression of ACOT2 protein |
CTD |
PMID:35357534 |
|
NCBI chr 6:103,611,738...103,619,404
Ensembl chr 6:103,611,544...103,619,245
|
|
G |
Acot3 |
acyl-CoA thioesterase 3 |
increases expression |
ISO |
senecionine results in increased expression of ACOT3 protein |
CTD |
PMID:35357534 |
|
NCBI chr 6:103,682,518...103,688,735
Ensembl chr 6:103,682,596...103,688,427 Ensembl chr 6:103,682,596...103,688,427
|
|
G |
Acot4 |
acyl-CoA thioesterase 4 |
increases expression |
ISO |
senecionine results in increased expression of ACOT4 protein |
CTD |
PMID:35357534 |
|
NCBI chr 6:103,668,699...103,674,037
Ensembl chr 6:103,668,753...103,673,917
|
|
G |
Acsl3 |
acyl-CoA synthetase long-chain family member 3 |
decreases expression |
ISO |
senecionine results in decreased expression of ACSL3 mRNA |
CTD |
PMID:26100227 |
|
NCBI chr 9:80,115,164...80,164,636
Ensembl chr 9:80,115,112...80,164,627
|
|
G |
Acsl4 |
acyl-CoA synthetase long-chain family member 4 |
decreases expression |
ISO |
senecionine results in decreased expression of ACSL4 protein |
CTD |
PMID:35357534 |
|
NCBI chr X:105,942,794...106,006,573
Ensembl chr X:105,942,799...106,006,427
|
|
G |
Acsm3 |
acyl-CoA synthetase medium-chain family member 3 |
decreases expression |
ISO |
senecionine results in decreased expression of ACSM3 mRNA |
CTD |
PMID:26100227 |
|
NCBI chr 1:174,133,260...174,159,966
Ensembl chr 1:174,133,288...174,160,184
|
|
G |
Acss3 |
acyl-CoA synthetase short-chain family member 3 |
increases expression |
ISO |
senecionine results in increased expression of ACSS3 protein |
CTD |
PMID:35357534 |
|
NCBI chr 7:42,241,261...42,450,209
Ensembl chr 7:42,242,652...42,450,230
|
|
G |
Actg2 |
actin gamma 2, smooth muscle |
decreases expression |
EXP |
senecionine results in decreased expression of ACTG2 mRNA |
CTD |
PMID:34185104 |
|
NCBI chr 4:116,021,832...116,046,475
Ensembl chr 4:116,021,832...116,046,465
|
|
G |
Adam8 |
ADAM metallopeptidase domain 8 |
increases expression |
EXP |
senecionine results in increased expression of ADAM8 mRNA |
CTD |
PMID:32419051 |
|
NCBI chr 1:194,776,559...194,789,330
Ensembl chr 1:194,770,060...194,788,801
|
|
G |
Adh1c |
alcohol dehydrogenase 1C (class I), gamma polypeptide |
increases expression |
ISO |
senecionine results in increased expression of ADH1 protein |
CTD |
PMID:35357534 |
|
NCBI chr 2:226,797,303...226,808,892
Ensembl chr 2:226,797,303...226,808,892
|
|
G |
Aff3 |
ALF transcription elongation factor 3 |
decreases expression |
ISO |
senecionine results in decreased expression of AFF3 mRNA |
CTD |
PMID:26100227 |
|
NCBI chr 9:40,399,099...40,856,716
Ensembl chr 9:40,404,375...40,857,247
|
|
G |
Agxt |
alanine--glyoxylate aminotransferase |
decreases expression |
ISO |
senecionine results in decreased expression of AGXT mRNA |
CTD |
PMID:26100227 |
|
NCBI chr 9:93,675,384...93,685,337
Ensembl chr 9:93,675,384...93,685,336
|
|
G |
Aif1 |
allograft inflammatory factor 1 |
decreases expression |
ISO |
senecionine results in decreased expression of AIF1 protein |
CTD |
PMID:35357534 |
|
NCBI chr20:3,646,784...3,652,670
Ensembl chr20:3,646,777...3,652,668
|
|
G |
Akap12 |
A-kinase anchoring protein 12 |
increases expression |
ISO |
senecionine results in increased expression of AKAP12 protein |
CTD |
PMID:35357534 |
|
NCBI chr 1:40,730,123...40,819,863
Ensembl chr 1:40,730,123...40,819,886
|
|
G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
increases expression |
EXP |
senecionine results in increased expression of ALDH1A1 mRNA |
CTD |
PMID:32419051 |
|
NCBI chr 1:218,000,470...218,152,962
Ensembl chr 1:218,042,127...218,152,961
|
|
G |
Aldh1b1 |
aldehyde dehydrogenase 1 family, member B1 |
increases expression |
ISO |
senecionine results in increased expression of ALDH1B1 protein |
CTD |
PMID:35357534 |
|
NCBI chr 5:60,063,370...60,068,378
Ensembl chr 5:60,063,225...60,068,378
|
|
G |
Aldh6a1 |
aldehyde dehydrogenase 6 family, member A1 |
increases expression |
ISO |
senecionine results in increased expression of ALDH6A1 mRNA |
CTD |
PMID:26100227 |
|
NCBI chr 6:104,077,975...104,098,636
Ensembl chr 6:104,077,979...104,098,656
|
|
G |
Aldh8a1 |
aldehyde dehydrogenase 8 family, member A1 |
decreases expression |
ISO |
senecionine results in decreased expression of ALDH8A1 mRNA |
CTD |
PMID:26100227 |
|
NCBI chr 1:16,183,940...16,203,385
Ensembl chr 1:16,183,940...16,203,385
|
|
G |
Anapc2 |
anaphase promoting complex subunit 2 |
increases expression |
ISO |
senecionine results in increased expression of ANAPC2 protein |
CTD |
PMID:35357534 |
|
NCBI chr 3:8,086,434...8,098,182
Ensembl chr 3:8,086,462...8,098,178
|
|
G |
Ankrd1 |
ankyrin repeat domain 1 |
decreases expression |
EXP |
senecionine results in decreased expression of ANKRD1 mRNA |
CTD |
PMID:34185104 |
|
NCBI chr 1:233,815,851...233,834,891
Ensembl chr 1:233,815,851...233,834,919
|
|
G |
Anxa1 |
annexin A1 |
increases expression |
ISO |
senecionine results in increased expression of ANXA1 protein |
CTD |
PMID:35357534 |
|
NCBI chr 1:217,861,175...217,877,205
Ensembl chr 1:217,861,175...217,877,343
|
|
G |
Apcs |
amyloid P component, serum |
decreases expression |
ISO |
senecionine results in decreased expression of APCS protein |
CTD |
PMID:35357534 |
|
NCBI chr13:85,373,219...85,374,195
Ensembl chr13:85,373,220...85,374,298
|
|
G |
Apob |
apolipoprotein B |
decreases expression |
ISO |
senecionine results in decreased expression of APOB protein |
CTD |
PMID:35357534 |
|
NCBI chr 6:30,844,386...30,883,983
Ensembl chr 6:30,844,368...30,892,497
|
|
G |
Apoc1 |
apolipoprotein C1 |
decreases expression |
ISO |
senecionine results in decreased expression of APOC1 protein |
CTD |
PMID:35357534 |
|
NCBI chr 1:79,347,057...79,350,340
Ensembl chr 1:79,346,136...79,350,375
|
|
G |
Apoh |
apolipoprotein H |
decreases expression |
ISO |
senecionine results in decreased expression of APOH protein |
CTD |
PMID:35357534 |
|
NCBI chr10:93,342,435...93,356,334
Ensembl chr10:93,310,977...93,356,329
|
|
G |
Apom |
apolipoprotein M |
decreases expression |
ISO |
senecionine results in decreased expression of APOM protein |
CTD |
PMID:35357534 |
|
NCBI chr20:3,690,950...3,693,550
Ensembl chr20:3,688,413...3,693,550
|
|
G |
Aqp4 |
aquaporin 4 |
decreases expression |
ISO |
senecionine results in decreased expression of AQP4 protein |
CTD |
PMID:35357534 |
|
NCBI chr18:6,507,903...6,524,558
Ensembl chr18:6,507,903...6,524,856
|
|
G |
Aqp8 |
aquaporin 8 |
increases expression |
ISO |
senecionine results in increased expression of AQP8 protein |
CTD |
PMID:35357534 |
|
NCBI chr 1:177,993,313...177,999,158
Ensembl chr 1:177,993,305...177,999,158
|
|
G |
Areg |
amphiregulin |
increases expression |
ISO |
senecionine results in increased expression of AREG mRNA |
CTD |
PMID:26100227 |
|
NCBI chr14:16,972,185...16,981,443
Ensembl chr14:16,972,187...16,981,535
|
|
G |
Arhgap11a |
Rho GTPase activating protein 11A |
increases expression |
EXP |
senecionine results in increased expression of ARHGAP11A mRNA |
CTD |
PMID:32419051 |
|
NCBI chr 3:100,590,865...100,607,146
Ensembl chr 3:100,590,865...100,607,559
|
|
G |
Arl6ip1 |
ARL6 interacting reticulophagy regulator 1 |
decreases expression |
ISO |
senecionine results in decreased expression of ARL6IP1 protein |
CTD |
PMID:35357534 |
|
NCBI chr 1:172,430,475...172,439,990
Ensembl chr 1:172,430,489...172,439,994
|
|
G |
Arl6ip4 |
ARF like GTPase 6 interacting protein 4 |
decreases expression |
ISO |
senecionine results in decreased expression of ARL6IP4 protein |
CTD |
PMID:35357534 |
|
NCBI chr12:32,479,623...32,481,768
Ensembl chr12:32,479,625...32,481,799
|
|
G |
Atad2 |
ATPase family, AAA domain containing 2 |
increases expression |
EXP |
senecionine results in increased expression of ATAD2 mRNA |
CTD |
PMID:32419051 |
|
NCBI chr 7:89,634,123...89,676,738
Ensembl chr 7:89,634,123...89,676,738
|
|
G |
Atf3 |
activating transcription factor 3 |
increases expression |
ISO |
senecionine results in increased expression of ATF3 protein |
CTD |
PMID:35357534 |
|
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631
|
|
G |
Atp13a2 |
ATPase cation transporting 13A2 |
decreases expression |
ISO |
senecionine results in decreased expression of ATP13A2 protein |
CTD |
PMID:35357534 |
|
NCBI chr 5:153,292,722...153,312,143
Ensembl chr 5:153,292,751...153,312,139
|
|
G |
Atp2a3 |
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3 |
increases expression |
ISO |
senecionine results in increased expression of ATP2A3 protein |
CTD |
PMID:35357534 |
|
NCBI chr10:57,581,742...57,612,758
Ensembl chr10:57,582,128...57,612,748
|
|
G |
Atp5if1 |
ATP synthase inhibitory factor subunit 1 |
decreases expression |
ISO |
senecionine results in decreased expression of ATP5IF1 protein |
CTD |
PMID:35357534 |
|
NCBI chr 5:144,738,950...144,742,668
Ensembl chr 5:144,738,950...144,742,668
|
|
G |
Atp6v1h |
ATPase H+ transporting V1 subunit H |
increases expression |
ISO |
senecionine results in increased expression of ATP6V1H protein |
CTD |
PMID:35357534 |
|
NCBI chr 5:14,379,029...14,484,703
Ensembl chr 5:14,378,257...14,537,962
|
|
G |
Atpaf2 |
ATP synthase mitochondrial F1 complex assembly factor 2 |
increases expression |
ISO |
senecionine results in increased expression of ATPAF2 protein |
CTD |
PMID:35357534 |
|
NCBI chr10:45,205,658...45,221,891
Ensembl chr10:45,197,441...45,221,026
|
|
G |
Axin2 |
axin 2 |
decreases expression |
ISO |
senecionine results in decreased expression of AXIN2 mRNA |
CTD |
PMID:31606820 |
|
NCBI chr10:93,893,830...93,927,042
Ensembl chr10:93,899,245...93,926,231
|
|
G |
B3galt1 |
Beta-1,3-galactosyltransferase 1 |
decreases expression |
ISO |
senecionine results in decreased expression of B3GALT1 protein |
CTD |
PMID:35357534 |
|
NCBI chr 3:52,253,413...52,826,508
Ensembl chr 3:52,253,618...52,825,313
|
|
G |
Baat |
bile acid CoA:amino acid N-acyltransferase |
decreases expression |
EXP ISO |
senecionine results in decreased expression of BAAT mRNA |
CTD |
PMID:24641316 PMID:26100227 |
|
NCBI chr 5:63,851,668...63,860,641
Ensembl chr 5:63,850,705...63,860,685
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
decreases expression |
ISO |
senecionine results in decreased expression of BCL2L1 protein |
CTD |
PMID:29458164 |
|
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479 Ensembl chr 1:141,253,523...141,303,479
|
|
G |
Bcl3 |
BCL3, transcription coactivator |
increases expression |
ISO |
senecionine results in increased expression of BCL3 protein |
CTD |
PMID:35357534 |
|
NCBI chr 1:79,471,368...79,485,908
Ensembl chr 1:79,471,369...79,485,607
|
|
G |
Bnip3 |
BCL2 interacting protein 3 |
decreases expression |
ISO |
senecionine results in decreased expression of BNIP3 protein |
CTD |
PMID:35357534 |
|
NCBI chr 1:193,708,164...193,725,348
Ensembl chr 1:193,708,167...193,725,359
|
|
G |
Bod1l1 |
biorientation of chromosomes in cell division 1-like 1 |
decreases expression |
ISO |
senecionine results in decreased expression of BOD1L protein |
CTD |
PMID:35357534 |
|
NCBI chr14:69,108,483...69,163,255
Ensembl chr14:69,108,491...69,162,490
|
|
G |
Bpgm |
bisphosphoglycerate mutase |
increases expression |
ISO |
senecionine results in increased expression of BPGM protein |
CTD |
PMID:35357534 |
|
NCBI chr 4:63,139,730...63,168,581
Ensembl chr 4:63,140,018...63,168,581
|
|
G |
Btc |
betacellulin |
increases expression |
ISO |
senecionine results in increased expression of BTC protein |
CTD |
PMID:35357534 |
|
NCBI chr14:16,708,447...16,746,961
Ensembl chr14:16,707,982...16,747,049
|
|
G |
C3 |
complement C3 |
decreases expression |
ISO |
senecionine results in decreased expression of C3 protein |
CTD |
PMID:35357534 |
|
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
|
|
G |
C3ar1 |
complement C3a receptor 1 |
increases expression |
EXP |
senecionine results in increased expression of C3AR1 mRNA |
CTD |
PMID:34185104 |
|
NCBI chr 4:156,074,747...156,084,680
Ensembl chr 4:156,075,389...156,084,701
|
|
G |
C4b |
complement C4B |
decreases expression |
ISO |
senecionine results in decreased expression of C4B protein |
CTD |
PMID:35357534 |
|
NCBI chr20:4,197,371...4,211,684
Ensembl chr20:4,197,366...4,211,681
|
|
G |
C5 |
complement C5 |
decreases expression |
ISO |
senecionine results in decreased expression of C5 protein |
CTD |
PMID:35357534 |
|
NCBI chr 3:18,270,696...18,361,994
Ensembl chr 3:18,270,696...18,361,994
|
|
G |
|